Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spi1
|
ENSMUSG00000002111.8 | spleen focus forming virus (SFFV) proviral integration oncogene |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_91082970_91083249 | Spi1 | 701 | 0.522125 | 0.73 | 2.2e-10 | Click! |
chr2_91084555_91084824 | Spi1 | 2281 | 0.173598 | 0.60 | 1.4e-06 | Click! |
chr2_91083286_91083437 | Spi1 | 953 | 0.395538 | 0.55 | 1.6e-05 | Click! |
chr2_91098261_91098440 | Spi1 | 1570 | 0.248805 | 0.55 | 1.6e-05 | Click! |
chr2_91096572_91096871 | Spi1 | 59 | 0.953340 | 0.55 | 1.7e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14354416_14355184 | 73.93 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr14_14351950_14353283 | 36.30 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr1_86479174_86479713 | 30.85 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr3_65658208_65659857 | 30.11 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr9_32400635_32401003 | 28.74 |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
6834 |
0.18 |
chr4_137478244_137478657 | 26.99 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
9647 |
0.14 |
chr11_100938783_100940230 | 26.45 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr5_137530580_137532081 | 26.34 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr5_137349031_137350198 | 26.00 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr11_108424530_108425250 | 25.98 |
Cep112 |
centrosomal protein 112 |
302 |
0.86 |
chr2_153492229_153493481 | 25.76 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chrX_101428817_101430172 | 25.71 |
Nono |
non-POU-domain-containing, octamer binding protein |
61 |
0.96 |
chr12_79674954_79675872 | 25.55 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr1_64087943_64089121 | 25.38 |
Gm13748 |
predicted gene 13748 |
9878 |
0.19 |
chrX_123721926_123722462 | 24.93 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chrX_123943434_123943951 | 24.78 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr17_5798459_5798854 | 24.75 |
3300005D01Rik |
RIKEN cDNA 3300005D01 gene |
1 |
0.97 |
chr8_84979246_84980613 | 24.72 |
Junb |
jun B proto-oncogene |
1211 |
0.19 |
chr11_98941353_98942362 | 24.25 |
Rara |
retinoic acid receptor, alpha |
2145 |
0.18 |
chrX_123271195_123271712 | 24.24 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chrX_123500550_123501093 | 23.84 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr2_84810833_84811663 | 23.72 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
5019 |
0.11 |
chr15_102393639_102394041 | 23.34 |
Sp1 |
trans-acting transcription factor 1 |
12303 |
0.09 |
chr18_36405636_36405997 | 22.35 |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
40035 |
0.12 |
chrX_142680720_142682167 | 22.28 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr7_126975552_126976438 | 21.66 |
Cdiptos |
CDIP transferase, opposite strand |
57 |
0.51 |
chr8_122323502_122324203 | 21.38 |
Zfpm1 |
zinc finger protein, multitype 1 |
9846 |
0.13 |
chr14_70074487_70075571 | 21.01 |
Egr3 |
early growth response 3 |
2174 |
0.25 |
chr7_29453052_29453769 | 20.66 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
52042 |
0.1 |
chr15_98608664_98610204 | 20.58 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr9_65554974_65555491 | 20.44 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
6932 |
0.14 |
chrX_53052410_53053563 | 20.23 |
Gm28730 |
predicted gene 28730 |
173 |
0.64 |
chr5_129002551_129002777 | 19.97 |
Stx2 |
syntaxin 2 |
3029 |
0.26 |
chr2_153350750_153351114 | 19.62 |
Asxl1 |
additional sex combs like 1 |
3129 |
0.21 |
chr11_105125823_105126961 | 19.60 |
Mettl2 |
methyltransferase like 2 |
33 |
0.97 |
chr3_137980493_137981436 | 19.18 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
566 |
0.67 |
chr4_132747719_132747886 | 18.99 |
Smpdl3b |
sphingomyelin phosphodiesterase, acid-like 3B |
9450 |
0.12 |
chr7_101377706_101378260 | 18.87 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
207 |
0.89 |
chr9_32901255_32901639 | 18.78 |
Gm27162 |
predicted gene 27162 |
27519 |
0.18 |
chr11_19924323_19926342 | 18.70 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr1_34389196_34389610 | 18.25 |
Gm5266 |
predicted gene 5266 |
22032 |
0.09 |
chr7_92950785_92951181 | 18.17 |
Gm31663 |
predicted gene, 31663 |
28893 |
0.14 |
chr8_20817574_20818579 | 18.16 |
Gm20946 |
predicted gene, 20946 |
10277 |
0.15 |
chr8_70609185_70610414 | 18.10 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr2_32637968_32638334 | 18.10 |
Eng |
endoglin |
8444 |
0.07 |
chr12_13145384_13145901 | 18.07 |
Rpl21-ps2 |
ribosomal protein L21, pseudogene 2 |
4518 |
0.18 |
chr10_128525093_128526268 | 18.02 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr11_79006516_79006693 | 17.89 |
Ksr1 |
kinase suppressor of ras 1 |
13806 |
0.16 |
chr9_64045641_64045837 | 17.84 |
Gm25606 |
predicted gene, 25606 |
2757 |
0.18 |
chr7_80763876_80764435 | 17.83 |
Gm44649 |
predicted gene 44649 |
12310 |
0.17 |
chr16_96361545_96361779 | 17.83 |
Igsf5 |
immunoglobulin superfamily, member 5 |
6 |
0.63 |
chr9_65826224_65827697 | 17.80 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr10_127512528_127514054 | 17.74 |
Ndufa4l2 |
Ndufa4, mitochondrial complex associated like 2 |
1676 |
0.21 |
chr9_35105556_35106095 | 17.69 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
842 |
0.54 |
chr8_122547810_122548264 | 17.56 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3292 |
0.12 |
chr13_99307813_99308164 | 17.53 |
Ptcd2 |
pentatricopeptide repeat domain 2 |
36717 |
0.15 |
chr11_32542782_32542963 | 17.48 |
Stk10 |
serine/threonine kinase 10 |
9567 |
0.2 |
chr16_15889991_15890155 | 17.42 |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
1657 |
0.37 |
chr2_165884402_165885933 | 17.37 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr7_133052918_133053097 | 17.33 |
Ctbp2 |
C-terminal binding protein 2 |
22891 |
0.16 |
chr6_48700249_48700426 | 17.18 |
Gimap6 |
GTPase, IMAP family member 6 |
5899 |
0.08 |
chr14_75179359_75179560 | 17.11 |
Lcp1 |
lymphocyte cytosolic protein 1 |
3251 |
0.2 |
chr11_5505810_5506157 | 16.94 |
Gm11963 |
predicted gene 11963 |
7143 |
0.14 |
chr10_99268740_99269700 | 16.87 |
Gm34921 |
predicted gene, 34921 |
1226 |
0.27 |
chr5_66337123_66338408 | 16.84 |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
83 |
0.96 |
chr10_45066555_45067953 | 16.81 |
Prep |
prolyl endopeptidase |
51 |
0.97 |
chr16_49798847_49799219 | 16.81 |
Gm15518 |
predicted gene 15518 |
163 |
0.95 |
chr5_117133755_117134546 | 16.79 |
Taok3 |
TAO kinase 3 |
509 |
0.72 |
chr16_10689767_10690299 | 16.72 |
Gm15558 |
predicted gene 15558 |
6494 |
0.18 |
chr18_46404986_46405434 | 16.70 |
Gm4107 |
predicted gene 4107 |
21833 |
0.13 |
chr9_21846665_21847082 | 16.64 |
Dock6 |
dedicator of cytokinesis 6 |
5743 |
0.11 |
chr6_124919273_124920636 | 16.60 |
Ptms |
parathymosin |
149 |
0.88 |
chr2_120128702_120129052 | 16.59 |
Ehd4 |
EH-domain containing 4 |
848 |
0.58 |
chr16_91522182_91522356 | 16.58 |
Mir6367 |
microRNA 6367 |
5275 |
0.1 |
chr6_136789326_136789841 | 16.57 |
Gucy2c |
guanylate cyclase 2c |
7818 |
0.1 |
chr5_145116458_145116713 | 16.56 |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
2269 |
0.16 |
chr12_101028530_101029714 | 16.49 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chr9_108338578_108339700 | 16.46 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr10_127508848_127510720 | 16.43 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr5_121833479_121834291 | 16.42 |
1700008B11Rik |
RIKEN cDNA 1700008B11 gene |
1310 |
0.26 |
chr14_65345608_65345793 | 16.36 |
Zfp395 |
zinc finger protein 395 |
12689 |
0.15 |
chr2_170152169_170152320 | 16.35 |
Zfp217 |
zinc finger protein 217 |
4141 |
0.33 |
chr2_17510016_17510384 | 16.26 |
Nebl |
nebulette |
18124 |
0.22 |
chr15_36460470_36460815 | 16.21 |
Gm49224 |
predicted gene, 49224 |
23951 |
0.13 |
chr10_94931912_94932258 | 16.13 |
Plxnc1 |
plexin C1 |
9428 |
0.21 |
chr4_137367859_137368027 | 16.09 |
Cdc42 |
cell division cycle 42 |
10223 |
0.12 |
chr3_96564739_96564927 | 15.98 |
Gm15441 |
predicted gene 15441 |
1968 |
0.13 |
chr9_50616581_50617570 | 15.98 |
Nkapd1 |
NKAP domain containing 1 |
189 |
0.55 |
chr5_117133502_117133674 | 15.97 |
Taok3 |
TAO kinase 3 |
0 |
0.97 |
chr1_171171187_171171480 | 15.89 |
Mpz |
myelin protein zero |
11630 |
0.09 |
chr18_61767773_61768067 | 15.88 |
Afap1l1 |
actin filament associated protein 1-like 1 |
18691 |
0.14 |
chr10_127062800_127064205 | 15.83 |
Cdk4 |
cyclin-dependent kinase 4 |
32 |
0.93 |
chr18_12166800_12167170 | 15.78 |
Rmc1 |
regulator of MON1-CCZ1 |
1732 |
0.26 |
chr8_84197696_84198961 | 15.78 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr4_46643037_46643443 | 15.75 |
Tbc1d2 |
TBC1 domain family, member 2 |
6969 |
0.2 |
chr19_47432341_47432749 | 15.68 |
Sh3pxd2a |
SH3 and PX domains 2A |
22186 |
0.18 |
chr15_85669900_85671551 | 15.60 |
Lncppara |
long noncoding RNA near Ppara |
17109 |
0.13 |
chr1_162216776_162217075 | 15.53 |
Dnm3os |
dynamin 3, opposite strand |
698 |
0.48 |
chr5_115542702_115542988 | 15.51 |
Pxn |
paxillin |
69 |
0.94 |
chr7_4792408_4793492 | 15.51 |
Rpl28 |
ribosomal protein L28 |
40 |
0.93 |
chr9_109094576_109096217 | 15.48 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr4_140701770_140702866 | 15.36 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr8_70698268_70700333 | 15.35 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr12_8357354_8358033 | 15.35 |
Gm48071 |
predicted gene, 48071 |
20976 |
0.14 |
chr14_32861100_32861956 | 15.34 |
Vstm4 |
V-set and transmembrane domain containing 4 |
4772 |
0.2 |
chr2_4559355_4560175 | 15.31 |
Frmd4a |
FERM domain containing 4A |
9 |
0.98 |
chr1_180945219_180945959 | 15.22 |
Tmem63a |
transmembrane protein 63a |
317 |
0.79 |
chr7_28442816_28442990 | 15.22 |
Gmfg |
glia maturation factor, gamma |
204 |
0.86 |
chr12_85348346_85348497 | 15.21 |
Tmed10 |
transmembrane p24 trafficking protein 10 |
2499 |
0.16 |
chr5_129924913_129925078 | 15.21 |
Nupr1l |
nuclear protein transcriptional regulator 1 like |
14025 |
0.09 |
chr10_128779498_128779802 | 15.14 |
Rpsa-ps2 |
ribosomal protein SA, pseudogene 2 |
2400 |
0.13 |
chr19_4059281_4059805 | 15.14 |
Gstp3 |
glutathione S-transferase pi 3 |
26 |
0.92 |
chr5_92745758_92746287 | 15.12 |
Gm20500 |
predicted gene 20500 |
9817 |
0.19 |
chr5_139388247_139388459 | 15.10 |
Gpr146 |
G protein-coupled receptor 146 |
1432 |
0.28 |
chr13_41345941_41346221 | 15.07 |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated gene 9 |
13166 |
0.14 |
chr14_57084344_57084685 | 15.06 |
Gjb2 |
gap junction protein, beta 2 |
20188 |
0.13 |
chr7_16815354_16816404 | 15.05 |
Strn4 |
striatin, calmodulin binding protein 4 |
10 |
0.69 |
chr19_9931257_9931509 | 15.04 |
Gm36913 |
predicted gene, 36913 |
2849 |
0.12 |
chr11_75623907_75624305 | 15.02 |
Pitpna |
phosphatidylinositol transfer protein, alpha |
3435 |
0.14 |
chr11_106382523_106382839 | 14.99 |
Icam2 |
intercellular adhesion molecule 2 |
100 |
0.95 |
chr11_86586799_86587209 | 14.97 |
Vmp1 |
vacuole membrane protein 1 |
10 |
0.97 |
chr5_105718109_105718556 | 14.91 |
Lrrc8d |
leucine rich repeat containing 8D |
13057 |
0.22 |
chr4_10967879_10968217 | 14.86 |
Rps11-ps3 |
ribosomal protein S11, pseudogene 3 |
21440 |
0.16 |
chr2_30093353_30094532 | 14.85 |
Zdhhc12 |
zinc finger, DHHC domain containing 12 |
294 |
0.82 |
chr14_21032131_21032511 | 14.83 |
Vcl |
vinculin |
10318 |
0.18 |
chr17_6467913_6468580 | 14.83 |
Tmem181b-ps |
transmembrane protein 181B, pseudogene |
1224 |
0.43 |
chr2_120153745_120155075 | 14.78 |
Ehd4 |
EH-domain containing 4 |
52 |
0.97 |
chr10_84886211_84886658 | 14.76 |
Ric8b |
RIC8 guanine nucleotide exchange factor B |
31182 |
0.17 |
chr13_95764883_95765493 | 14.74 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
791 |
0.63 |
chr5_105649757_105649967 | 14.73 |
Lrrc8d |
leucine rich repeat containing 8D |
50107 |
0.13 |
chr1_135731863_135732606 | 14.64 |
Csrp1 |
cysteine and glycine-rich protein 1 |
3087 |
0.22 |
chr8_126805357_126806196 | 14.60 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
33457 |
0.16 |
chr15_83169975_83170350 | 14.58 |
Cyb5r3 |
cytochrome b5 reductase 3 |
15 |
0.95 |
chr7_90019647_90020145 | 14.54 |
E230029C05Rik |
RIKEN cDNA E230029C05 gene |
9263 |
0.13 |
chr15_97590838_97591009 | 14.51 |
Gm49506 |
predicted gene, 49506 |
32633 |
0.19 |
chr4_135254860_135255063 | 14.50 |
Clic4 |
chloride intracellular channel 4 (mitochondrial) |
17853 |
0.14 |
chr9_63757305_63758776 | 14.49 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr11_11684707_11686418 | 14.43 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr4_135314003_135314213 | 14.38 |
Gm12982 |
predicted gene 12982 |
6138 |
0.12 |
chr8_120040971_120041180 | 14.33 |
Gm15684 |
predicted gene 15684 |
4212 |
0.17 |
chr1_86268976_86269362 | 14.31 |
Armc9 |
armadillo repeat containing 9 |
24603 |
0.09 |
chr5_32745814_32745996 | 14.27 |
Pisd |
phosphatidylserine decarboxylase |
407 |
0.75 |
chr17_80825502_80826283 | 14.25 |
C230072F16Rik |
RIKEN cDNA C230072F16 gene |
70901 |
0.1 |
chr10_77211616_77211790 | 14.25 |
Col18a1 |
collagen, type XVIII, alpha 1 |
45155 |
0.11 |
chr7_139434111_139434466 | 14.21 |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
19766 |
0.22 |
chr3_116562756_116563068 | 14.20 |
Lrrc39 |
leucine rich repeat containing 39 |
61 |
0.93 |
chr11_115778758_115779568 | 14.20 |
Tmem94 |
transmembrane protein 94 |
1536 |
0.23 |
chr16_34036709_34036999 | 14.15 |
Kalrn |
kalirin, RhoGEF kinase |
20360 |
0.18 |
chr11_113651275_113651628 | 14.13 |
Slc39a11 |
solute carrier family 39 (metal ion transporter), member 11 |
1372 |
0.29 |
chr19_53080891_53081464 | 14.12 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chr13_106998676_106998920 | 14.11 |
Kif2a |
kinesin family member 2A |
2042 |
0.23 |
chr10_99840287_99840438 | 14.11 |
Gm47579 |
predicted gene, 47579 |
25658 |
0.18 |
chr19_47291265_47291699 | 14.07 |
Mir6995 |
microRNA 6995 |
17893 |
0.14 |
chr2_154765762_154765945 | 14.03 |
Gm14214 |
predicted gene 14214 |
4079 |
0.16 |
chr2_48949106_48950119 | 14.01 |
Mbd5 |
methyl-CpG binding domain protein 5 |
89 |
0.8 |
chr11_98786375_98786829 | 14.00 |
Msl1 |
male specific lethal 1 |
8914 |
0.1 |
chr11_60114297_60115906 | 13.98 |
4930412M03Rik |
RIKEN cDNA 4930412M03 gene |
129 |
0.95 |
chr6_5156500_5156801 | 13.97 |
Pon1 |
paraoxonase 1 |
37113 |
0.14 |
chr1_87626506_87626684 | 13.97 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
4921 |
0.19 |
chr1_23184834_23184985 | 13.94 |
Gm29506 |
predicted gene 29506 |
50764 |
0.11 |
chr3_84460630_84461321 | 13.87 |
Fhdc1 |
FH2 domain containing 1 |
7212 |
0.24 |
chr4_133169620_133169795 | 13.87 |
Wasf2 |
WAS protein family, member 2 |
6294 |
0.15 |
chr7_90041544_90041927 | 13.86 |
Gm44861 |
predicted gene 44861 |
962 |
0.45 |
chr15_77800538_77800855 | 13.85 |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
12535 |
0.13 |
chr3_88509686_88510447 | 13.83 |
Lmna |
lamin A |
110 |
0.91 |
chr5_122274832_122275061 | 13.83 |
Pptc7 |
PTC7 protein phosphatase homolog |
9419 |
0.11 |
chr8_41016197_41016557 | 13.82 |
Mtus1 |
mitochondrial tumor suppressor 1 |
57 |
0.95 |
chr2_121036499_121036885 | 13.81 |
Epb42 |
erythrocyte membrane protein band 4.2 |
11 |
0.96 |
chr7_103811151_103811488 | 13.80 |
Hbb-bt |
hemoglobin, beta adult t chain |
2677 |
0.09 |
chr7_4684281_4684888 | 13.79 |
Hspbp1 |
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
77 |
0.93 |
chr11_103382021_103382275 | 13.75 |
Plekhm1 |
pleckstrin homology domain containing, family M (with RUN domain) member 1 |
12620 |
0.12 |
chr17_84181102_84182153 | 13.66 |
Gm36279 |
predicted gene, 36279 |
4129 |
0.18 |
chr11_53795189_53795552 | 13.64 |
Gm12216 |
predicted gene 12216 |
505 |
0.69 |
chr1_172513961_172514252 | 13.60 |
Gm37125 |
predicted gene, 37125 |
857 |
0.42 |
chr10_93731269_93731731 | 13.60 |
Gm15963 |
predicted gene 15963 |
3293 |
0.2 |
chr1_184864464_184864706 | 13.60 |
Mtarc2 |
mitochondrial amidoxime reducing component 2 |
18134 |
0.14 |
chr15_55089779_55091008 | 13.58 |
Dscc1 |
DNA replication and sister chromatid cohesion 1 |
87 |
0.96 |
chr7_127091121_127091448 | 13.56 |
AI467606 |
expressed sequence AI467606 |
75 |
0.92 |
chr14_26638315_26638978 | 13.55 |
Arf4 |
ADP-ribosylation factor 4 |
299 |
0.6 |
chr2_92983578_92983765 | 13.52 |
Prdm11 |
PR domain containing 11 |
30239 |
0.16 |
chr15_59047713_59048081 | 13.50 |
Mtss1 |
MTSS I-BAR domain containing 1 |
7300 |
0.23 |
chr8_82387722_82387873 | 13.47 |
Il15 |
interleukin 15 |
10830 |
0.24 |
chr9_123497975_123498146 | 13.44 |
Limd1 |
LIM domains containing 1 |
12004 |
0.17 |
chr16_72699156_72700074 | 13.43 |
Robo1 |
roundabout guidance receptor 1 |
36411 |
0.24 |
chr11_90726852_90727036 | 13.43 |
Tom1l1 |
target of myb1-like 1 (chicken) |
38578 |
0.15 |
chr8_46778227_46778378 | 13.42 |
Gm31172 |
predicted gene, 31172 |
7317 |
0.15 |
chr3_101430437_101431033 | 13.41 |
Gm42538 |
predicted gene 42538 |
3799 |
0.2 |
chr5_115522010_115522417 | 13.41 |
Pxn |
paxillin |
1908 |
0.17 |
chr7_143389159_143390008 | 13.40 |
4933417O13Rik |
RIKEN cDNA 4933417O13 gene |
24958 |
0.12 |
chr16_93603515_93604383 | 13.40 |
Setd4 |
SET domain containing 4 |
114 |
0.94 |
chr8_12041733_12042011 | 13.39 |
B020031H02Rik |
RIKEN cDNA B020031H02 gene |
93533 |
0.07 |
chr14_51008244_51008769 | 13.39 |
Rnase10 |
ribonuclease, RNase A family, 10 (non-active) |
577 |
0.54 |
chr7_132813190_132814038 | 13.38 |
Fam53b |
family with sequence similarity 53, member B |
86 |
0.97 |
chr7_17062144_17063331 | 13.37 |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
310 |
0.81 |
chr9_66181229_66181417 | 13.37 |
Dapk2 |
death-associated protein kinase 2 |
23088 |
0.17 |
chr6_47812781_47813882 | 13.35 |
Pdia4 |
protein disulfide isomerase associated 4 |
33 |
0.95 |
chr5_43855901_43856053 | 13.33 |
Cd38 |
CD38 antigen |
12576 |
0.1 |
chr16_94519149_94519474 | 13.31 |
Vps26c |
VPS26 endosomal protein sorting factor C |
7083 |
0.18 |
chr13_5592488_5592779 | 13.30 |
Gm35330 |
predicted gene, 35330 |
21505 |
0.26 |
chr7_35116712_35116864 | 13.29 |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
2505 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.5 | 58.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
13.4 | 26.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
12.5 | 37.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
12.5 | 25.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
12.2 | 49.0 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
11.6 | 23.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
11.6 | 34.7 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
10.4 | 10.4 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
10.4 | 31.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
10.3 | 30.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
9.8 | 29.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
9.6 | 28.9 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
8.6 | 25.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
8.3 | 24.9 | GO:0002432 | granuloma formation(GO:0002432) |
8.3 | 24.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
8.2 | 32.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
8.2 | 8.2 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
8.2 | 40.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
8.1 | 16.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
8.1 | 16.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
8.1 | 8.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
8.1 | 8.1 | GO:0070384 | Harderian gland development(GO:0070384) |
8.0 | 32.0 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
7.9 | 47.3 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
7.9 | 23.6 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
7.8 | 23.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
7.7 | 7.7 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
7.7 | 30.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
7.7 | 30.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
7.6 | 22.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
7.6 | 22.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
7.5 | 22.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
7.5 | 22.5 | GO:0000087 | mitotic M phase(GO:0000087) |
7.3 | 7.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
7.3 | 21.8 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
7.2 | 21.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
7.2 | 28.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
7.2 | 7.2 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
7.2 | 28.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
7.0 | 21.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
7.0 | 28.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
7.0 | 13.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
6.9 | 20.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
6.8 | 81.9 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
6.7 | 20.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
6.7 | 53.9 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
6.7 | 33.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
6.7 | 26.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
6.7 | 26.6 | GO:0050904 | diapedesis(GO:0050904) |
6.6 | 26.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
6.6 | 19.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
6.5 | 26.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
6.4 | 19.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
6.4 | 32.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
6.4 | 25.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
6.4 | 25.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
6.3 | 12.7 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
6.3 | 6.3 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
6.3 | 25.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
6.3 | 18.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
6.3 | 12.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
6.1 | 18.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
6.1 | 18.2 | GO:0003166 | bundle of His development(GO:0003166) |
6.1 | 12.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
6.0 | 18.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
6.0 | 18.0 | GO:1902896 | terminal web assembly(GO:1902896) |
6.0 | 11.9 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
5.9 | 23.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
5.9 | 17.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
5.9 | 17.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
5.8 | 17.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
5.8 | 17.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
5.8 | 11.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
5.8 | 28.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
5.8 | 5.8 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
5.7 | 17.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
5.7 | 11.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
5.7 | 34.3 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
5.6 | 22.5 | GO:0006116 | NADH oxidation(GO:0006116) |
5.6 | 50.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
5.6 | 16.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
5.6 | 5.6 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
5.6 | 16.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
5.6 | 27.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
5.5 | 5.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
5.5 | 94.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
5.5 | 27.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
5.5 | 5.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
5.5 | 16.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
5.4 | 37.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
5.4 | 21.7 | GO:0051031 | tRNA transport(GO:0051031) |
5.4 | 16.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
5.4 | 21.4 | GO:0070836 | caveola assembly(GO:0070836) |
5.4 | 5.4 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) regulation of relaxation of cardiac muscle(GO:1901897) |
5.3 | 16.0 | GO:0008228 | opsonization(GO:0008228) |
5.3 | 15.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
5.3 | 10.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
5.3 | 15.8 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
5.2 | 5.2 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
5.2 | 36.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
5.2 | 25.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
5.2 | 10.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
5.1 | 20.6 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
5.1 | 15.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
5.1 | 15.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
5.1 | 20.3 | GO:0007296 | vitellogenesis(GO:0007296) |
5.1 | 5.1 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
5.1 | 45.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
5.0 | 30.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
5.0 | 35.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
5.0 | 20.0 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
5.0 | 9.9 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
5.0 | 14.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
5.0 | 9.9 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
5.0 | 5.0 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
4.9 | 14.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
4.9 | 14.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
4.9 | 14.7 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
4.9 | 29.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
4.9 | 29.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
4.9 | 9.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
4.9 | 78.0 | GO:0006907 | pinocytosis(GO:0006907) |
4.9 | 19.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
4.8 | 14.5 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
4.7 | 14.2 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
4.7 | 14.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
4.7 | 4.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
4.7 | 4.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
4.7 | 9.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
4.7 | 37.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
4.7 | 14.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
4.6 | 23.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
4.6 | 32.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
4.6 | 23.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
4.6 | 36.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
4.6 | 4.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
4.6 | 13.7 | GO:0040031 | snRNA modification(GO:0040031) |
4.5 | 18.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
4.5 | 4.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
4.5 | 9.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
4.5 | 40.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
4.5 | 66.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
4.5 | 8.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
4.4 | 8.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
4.4 | 4.4 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
4.4 | 13.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
4.4 | 17.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
4.4 | 13.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
4.4 | 4.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
4.4 | 13.1 | GO:0008050 | female courtship behavior(GO:0008050) |
4.4 | 17.4 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
4.4 | 13.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
4.4 | 39.2 | GO:0051014 | actin filament severing(GO:0051014) |
4.3 | 21.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
4.3 | 17.3 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
4.3 | 13.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
4.3 | 12.9 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
4.3 | 4.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
4.3 | 12.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
4.3 | 8.5 | GO:0032439 | endosome localization(GO:0032439) |
4.3 | 8.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
4.3 | 8.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
4.2 | 4.2 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
4.2 | 59.0 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
4.2 | 4.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
4.2 | 16.8 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
4.2 | 8.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
4.2 | 21.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
4.2 | 21.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
4.2 | 8.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
4.2 | 16.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
4.2 | 12.5 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
4.2 | 8.3 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
4.2 | 12.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
4.1 | 16.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
4.1 | 70.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
4.1 | 16.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
4.1 | 16.5 | GO:0018214 | protein carboxylation(GO:0018214) |
4.1 | 16.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
4.1 | 8.2 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
4.1 | 12.3 | GO:0042117 | monocyte activation(GO:0042117) |
4.1 | 8.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
4.1 | 12.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
4.1 | 16.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
4.1 | 12.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
4.1 | 16.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
4.1 | 20.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
4.0 | 24.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
4.0 | 4.0 | GO:0070627 | ferrous iron import(GO:0070627) |
4.0 | 20.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
4.0 | 8.0 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
4.0 | 16.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
4.0 | 12.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
4.0 | 4.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
4.0 | 4.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
4.0 | 11.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
3.9 | 7.9 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
3.9 | 3.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
3.9 | 3.9 | GO:0003096 | renal sodium ion transport(GO:0003096) |
3.9 | 51.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
3.9 | 15.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
3.9 | 11.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
3.9 | 15.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
3.9 | 54.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
3.9 | 7.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
3.8 | 3.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
3.8 | 11.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
3.8 | 11.4 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
3.8 | 3.8 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
3.8 | 15.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
3.8 | 11.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
3.8 | 11.3 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
3.8 | 3.8 | GO:0051593 | response to folic acid(GO:0051593) |
3.8 | 3.8 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
3.7 | 11.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
3.7 | 29.8 | GO:0010226 | response to lithium ion(GO:0010226) |
3.7 | 11.2 | GO:0007525 | somatic muscle development(GO:0007525) |
3.7 | 11.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
3.7 | 7.4 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
3.7 | 11.1 | GO:0018343 | protein farnesylation(GO:0018343) |
3.7 | 7.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
3.7 | 18.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
3.7 | 7.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
3.7 | 3.7 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
3.7 | 7.3 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
3.6 | 3.6 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
3.6 | 14.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
3.6 | 7.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
3.6 | 18.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
3.6 | 10.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
3.6 | 10.8 | GO:0021570 | rhombomere 4 development(GO:0021570) |
3.6 | 21.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
3.6 | 3.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
3.6 | 7.2 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
3.6 | 28.7 | GO:0046697 | decidualization(GO:0046697) |
3.6 | 7.2 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
3.6 | 10.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
3.6 | 10.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.6 | 10.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
3.6 | 21.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
3.5 | 39.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
3.5 | 10.6 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
3.5 | 7.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
3.5 | 14.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
3.5 | 21.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
3.5 | 10.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
3.5 | 3.5 | GO:0010958 | regulation of amino acid import(GO:0010958) |
3.5 | 7.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.5 | 17.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
3.5 | 3.5 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
3.5 | 3.5 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
3.5 | 6.9 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
3.5 | 17.3 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
3.5 | 13.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
3.5 | 13.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
3.4 | 20.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
3.4 | 20.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
3.4 | 20.5 | GO:0060613 | fat pad development(GO:0060613) |
3.4 | 3.4 | GO:0002159 | desmosome assembly(GO:0002159) |
3.4 | 3.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
3.4 | 6.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
3.4 | 27.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
3.4 | 6.8 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
3.4 | 3.4 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
3.4 | 13.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
3.4 | 13.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
3.4 | 10.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
3.4 | 10.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
3.4 | 20.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
3.4 | 47.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
3.4 | 3.4 | GO:0003143 | embryonic heart tube morphogenesis(GO:0003143) |
3.3 | 13.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
3.3 | 3.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
3.3 | 10.0 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
3.3 | 6.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
3.3 | 3.3 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
3.3 | 6.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
3.3 | 10.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
3.3 | 3.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
3.3 | 6.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
3.3 | 6.6 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
3.3 | 13.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
3.3 | 29.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
3.3 | 26.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
3.3 | 22.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
3.3 | 3.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
3.3 | 9.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
3.2 | 6.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
3.2 | 19.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
3.2 | 9.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
3.2 | 3.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
3.2 | 9.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
3.2 | 9.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
3.2 | 6.4 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
3.2 | 9.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
3.2 | 32.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
3.2 | 32.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
3.2 | 12.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
3.2 | 9.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
3.2 | 9.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
3.2 | 9.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
3.2 | 9.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
3.2 | 12.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
3.2 | 15.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
3.2 | 37.9 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
3.1 | 9.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
3.1 | 9.4 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
3.1 | 9.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
3.1 | 9.4 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
3.1 | 12.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
3.1 | 6.2 | GO:0035973 | aggrephagy(GO:0035973) |
3.1 | 15.6 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
3.1 | 6.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
3.1 | 3.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
3.1 | 15.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
3.1 | 9.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
3.1 | 6.2 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
3.1 | 9.3 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
3.1 | 9.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
3.1 | 6.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
3.1 | 9.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
3.1 | 3.1 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
3.1 | 6.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
3.1 | 18.4 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
3.1 | 15.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
3.1 | 15.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
3.1 | 6.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
3.1 | 6.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
3.1 | 3.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
3.0 | 9.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
3.0 | 3.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
3.0 | 36.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
3.0 | 18.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
3.0 | 6.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
3.0 | 39.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
3.0 | 9.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
3.0 | 6.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
3.0 | 9.0 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
3.0 | 9.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
3.0 | 20.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
3.0 | 8.9 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
3.0 | 14.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
3.0 | 23.7 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
3.0 | 8.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
3.0 | 8.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
3.0 | 3.0 | GO:1903557 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
2.9 | 8.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
2.9 | 2.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
2.9 | 8.8 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
2.9 | 5.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
2.9 | 5.9 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
2.9 | 23.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.9 | 55.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
2.9 | 29.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
2.9 | 8.7 | GO:0015886 | heme transport(GO:0015886) |
2.9 | 11.7 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
2.9 | 2.9 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
2.9 | 11.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.9 | 11.6 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
2.9 | 8.7 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
2.9 | 8.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
2.9 | 20.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
2.9 | 2.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
2.9 | 23.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
2.9 | 11.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
2.9 | 34.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
2.9 | 2.9 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
2.9 | 2.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
2.9 | 5.7 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
2.9 | 14.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
2.9 | 2.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.8 | 14.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
2.8 | 8.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
2.8 | 28.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
2.8 | 2.8 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
2.8 | 2.8 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
2.8 | 28.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
2.8 | 5.6 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
2.8 | 8.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
2.8 | 11.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
2.8 | 36.3 | GO:0071800 | podosome assembly(GO:0071800) |
2.8 | 8.3 | GO:0035483 | gastric emptying(GO:0035483) |
2.8 | 16.6 | GO:0048539 | bone marrow development(GO:0048539) |
2.8 | 24.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
2.8 | 2.8 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
2.8 | 11.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.8 | 8.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
2.8 | 19.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
2.7 | 8.2 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
2.7 | 2.7 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
2.7 | 2.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
2.7 | 8.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
2.7 | 10.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
2.7 | 2.7 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.7 | 24.4 | GO:0007097 | nuclear migration(GO:0007097) |
2.7 | 5.4 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
2.7 | 5.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
2.7 | 16.3 | GO:0051639 | actin filament network formation(GO:0051639) |
2.7 | 43.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
2.7 | 8.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.7 | 2.7 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
2.7 | 2.7 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
2.7 | 2.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
2.7 | 10.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.7 | 40.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
2.7 | 8.0 | GO:0061450 | trophoblast cell migration(GO:0061450) |
2.7 | 8.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.7 | 8.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
2.7 | 23.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
2.7 | 8.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
2.7 | 10.6 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
2.7 | 58.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
2.7 | 2.7 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
2.7 | 5.3 | GO:0032782 | bile acid secretion(GO:0032782) |
2.6 | 2.6 | GO:1902075 | cellular response to salt(GO:1902075) |
2.6 | 13.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
2.6 | 7.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.6 | 18.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
2.6 | 7.9 | GO:0042938 | dipeptide transport(GO:0042938) |
2.6 | 10.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
2.6 | 5.2 | GO:0006573 | valine metabolic process(GO:0006573) |
2.6 | 13.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.6 | 15.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
2.6 | 2.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
2.6 | 2.6 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
2.6 | 13.0 | GO:0001842 | neural fold formation(GO:0001842) |
2.6 | 36.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
2.6 | 20.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
2.6 | 10.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
2.6 | 13.0 | GO:0051195 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
2.6 | 10.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
2.6 | 13.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
2.6 | 5.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
2.6 | 2.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
2.6 | 23.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
2.6 | 10.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.6 | 15.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
2.6 | 12.8 | GO:0018101 | protein citrullination(GO:0018101) |
2.6 | 2.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.5 | 7.6 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
2.5 | 22.9 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
2.5 | 15.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.5 | 5.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.5 | 5.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
2.5 | 12.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.5 | 10.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
2.5 | 5.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
2.5 | 10.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.5 | 15.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
2.5 | 7.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
2.5 | 7.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.5 | 20.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
2.5 | 17.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
2.5 | 5.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
2.5 | 2.5 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
2.5 | 7.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.5 | 5.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
2.5 | 2.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
2.5 | 2.5 | GO:0002434 | immune complex clearance(GO:0002434) |
2.5 | 7.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.5 | 17.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.5 | 9.8 | GO:0018904 | ether metabolic process(GO:0018904) |
2.5 | 2.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
2.5 | 9.8 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
2.5 | 9.8 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
2.4 | 9.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
2.4 | 12.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.4 | 2.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
2.4 | 9.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
2.4 | 2.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
2.4 | 17.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
2.4 | 4.9 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
2.4 | 7.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
2.4 | 2.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
2.4 | 4.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.4 | 4.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.4 | 7.2 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
2.4 | 9.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
2.4 | 4.8 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
2.4 | 4.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
2.4 | 16.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
2.4 | 2.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
2.4 | 4.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
2.4 | 7.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
2.4 | 7.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
2.4 | 4.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
2.4 | 11.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
2.3 | 7.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
2.3 | 7.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
2.3 | 25.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
2.3 | 16.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
2.3 | 7.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.3 | 2.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
2.3 | 7.0 | GO:0015705 | iodide transport(GO:0015705) |
2.3 | 20.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
2.3 | 20.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
2.3 | 6.9 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
2.3 | 16.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
2.3 | 9.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
2.3 | 20.7 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
2.3 | 6.9 | GO:0060056 | mammary gland involution(GO:0060056) |
2.3 | 32.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
2.3 | 2.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
2.3 | 20.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.3 | 11.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
2.3 | 2.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
2.3 | 13.6 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
2.3 | 2.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
2.3 | 2.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
2.3 | 6.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.3 | 2.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
2.3 | 9.0 | GO:0030049 | muscle filament sliding(GO:0030049) |
2.3 | 9.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
2.3 | 9.0 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
2.3 | 20.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
2.3 | 2.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
2.2 | 15.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
2.2 | 6.7 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
2.2 | 4.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
2.2 | 11.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
2.2 | 13.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
2.2 | 71.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
2.2 | 4.5 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
2.2 | 4.5 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
2.2 | 6.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
2.2 | 8.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
2.2 | 2.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
2.2 | 30.9 | GO:0017144 | drug metabolic process(GO:0017144) |
2.2 | 6.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
2.2 | 8.8 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
2.2 | 11.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
2.2 | 2.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.2 | 13.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
2.2 | 6.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
2.2 | 8.8 | GO:0033194 | response to hydroperoxide(GO:0033194) |
2.2 | 2.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
2.2 | 4.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
2.2 | 2.2 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) |
2.2 | 4.4 | GO:0016264 | gap junction assembly(GO:0016264) |
2.2 | 15.2 | GO:0015825 | L-serine transport(GO:0015825) |
2.2 | 10.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
2.2 | 4.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
2.2 | 2.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
2.2 | 2.2 | GO:0072275 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
2.2 | 2.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
2.2 | 10.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
2.2 | 8.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
2.2 | 6.5 | GO:0015671 | oxygen transport(GO:0015671) |
2.2 | 28.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
2.2 | 25.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
2.2 | 10.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
2.1 | 27.9 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
2.1 | 19.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
2.1 | 2.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
2.1 | 4.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
2.1 | 4.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
2.1 | 10.7 | GO:0006525 | arginine metabolic process(GO:0006525) |
2.1 | 6.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
2.1 | 2.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
2.1 | 6.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
2.1 | 46.7 | GO:0006301 | postreplication repair(GO:0006301) |
2.1 | 6.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
2.1 | 8.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
2.1 | 6.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.1 | 14.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
2.1 | 2.1 | GO:0032347 | regulation of aldosterone biosynthetic process(GO:0032347) |
2.1 | 16.9 | GO:0009437 | carnitine metabolic process(GO:0009437) |
2.1 | 4.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
2.1 | 27.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
2.1 | 4.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.1 | 6.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.1 | 8.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
2.1 | 12.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
2.1 | 2.1 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
2.1 | 8.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
2.1 | 4.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.1 | 6.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
2.1 | 8.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
2.1 | 4.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.1 | 8.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
2.1 | 10.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
2.1 | 4.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
2.1 | 8.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
2.1 | 6.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.1 | 6.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
2.1 | 12.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
2.1 | 2.1 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
2.1 | 4.1 | GO:0015793 | glycerol transport(GO:0015793) |
2.1 | 4.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
2.1 | 10.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
2.0 | 8.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
2.0 | 2.0 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
2.0 | 14.3 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
2.0 | 2.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.0 | 4.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
2.0 | 12.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
2.0 | 4.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
2.0 | 4.1 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
2.0 | 4.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
2.0 | 26.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
2.0 | 26.4 | GO:0048821 | erythrocyte development(GO:0048821) |
2.0 | 2.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
2.0 | 10.1 | GO:0006548 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.0 | 6.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
2.0 | 6.0 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
2.0 | 2.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
2.0 | 24.1 | GO:0034340 | response to type I interferon(GO:0034340) |
2.0 | 20.1 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
2.0 | 12.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
2.0 | 6.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
2.0 | 2.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
2.0 | 18.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
2.0 | 10.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
2.0 | 4.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
2.0 | 6.0 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
2.0 | 4.0 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.0 | 7.9 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.0 | 6.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
2.0 | 45.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
2.0 | 4.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
2.0 | 9.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.0 | 5.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
2.0 | 3.9 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
2.0 | 21.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
2.0 | 2.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
2.0 | 2.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
2.0 | 3.9 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
2.0 | 5.9 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
2.0 | 3.9 | GO:0002215 | defense response to nematode(GO:0002215) |
2.0 | 5.9 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
1.9 | 3.9 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
1.9 | 3.9 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
1.9 | 5.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.9 | 3.9 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
1.9 | 5.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.9 | 17.3 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
1.9 | 5.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.9 | 5.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.9 | 3.8 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.9 | 7.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.9 | 3.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.9 | 3.8 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
1.9 | 7.6 | GO:0032264 | IMP salvage(GO:0032264) |
1.9 | 9.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.9 | 5.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.9 | 15.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.9 | 15.2 | GO:0030811 | regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
1.9 | 22.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.9 | 11.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.9 | 3.8 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.9 | 5.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.9 | 1.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.9 | 3.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.9 | 18.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
1.9 | 1.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.9 | 11.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
1.9 | 1.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
1.9 | 13.1 | GO:0002467 | germinal center formation(GO:0002467) |
1.9 | 7.5 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
1.9 | 1.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.9 | 9.3 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
1.9 | 1.9 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.9 | 9.3 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
1.9 | 3.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.9 | 1.9 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.9 | 14.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.8 | 1.8 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.8 | 1.8 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
1.8 | 22.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.8 | 5.5 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
1.8 | 1.8 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.8 | 9.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
1.8 | 3.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.8 | 7.3 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
1.8 | 9.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.8 | 1.8 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
1.8 | 1.8 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.8 | 9.1 | GO:0009249 | protein lipoylation(GO:0009249) |
1.8 | 3.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.8 | 5.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
1.8 | 9.0 | GO:0006477 | protein sulfation(GO:0006477) |
1.8 | 1.8 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
1.8 | 21.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.8 | 8.9 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
1.8 | 5.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.8 | 5.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.8 | 1.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.8 | 5.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.8 | 1.8 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.8 | 1.8 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.8 | 3.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.8 | 8.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
1.8 | 1.8 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.8 | 1.8 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
1.8 | 7.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.8 | 3.5 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
1.8 | 7.1 | GO:0016266 | O-glycan processing(GO:0016266) |
1.8 | 1.8 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
1.8 | 17.6 | GO:0009109 | coenzyme catabolic process(GO:0009109) cofactor catabolic process(GO:0051187) |
1.8 | 1.8 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
1.8 | 1.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.8 | 19.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.8 | 8.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.8 | 3.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.8 | 8.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.8 | 8.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.7 | 5.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.7 | 3.5 | GO:0006706 | steroid catabolic process(GO:0006706) |
1.7 | 8.7 | GO:0097421 | liver regeneration(GO:0097421) |
1.7 | 7.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.7 | 8.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.7 | 1.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.7 | 20.8 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
1.7 | 1.7 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
1.7 | 3.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.7 | 1.7 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
1.7 | 15.5 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
1.7 | 1.7 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
1.7 | 8.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.7 | 10.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.7 | 1.7 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
1.7 | 6.9 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
1.7 | 6.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.7 | 3.4 | GO:0007494 | midgut development(GO:0007494) |
1.7 | 1.7 | GO:0015755 | fructose transport(GO:0015755) |
1.7 | 10.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.7 | 5.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
1.7 | 1.7 | GO:0061724 | lipophagy(GO:0061724) |
1.7 | 3.4 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
1.7 | 3.4 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
1.7 | 5.1 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
1.7 | 5.1 | GO:0015871 | choline transport(GO:0015871) |
1.7 | 1.7 | GO:0016556 | mRNA modification(GO:0016556) |
1.7 | 6.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.7 | 1.7 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
1.7 | 1.7 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
1.7 | 3.4 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.7 | 1.7 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.7 | 1.7 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.7 | 6.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
1.7 | 6.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.7 | 1.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.7 | 3.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.7 | 15.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.7 | 5.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.7 | 6.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.7 | 1.7 | GO:0003383 | apical constriction(GO:0003383) |
1.7 | 3.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.7 | 6.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.7 | 29.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
1.7 | 5.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.7 | 8.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
1.6 | 24.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
1.6 | 6.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.6 | 4.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.6 | 1.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.6 | 4.9 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.6 | 6.6 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.6 | 4.9 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.6 | 4.9 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
1.6 | 14.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.6 | 9.8 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.6 | 4.9 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.6 | 4.9 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
1.6 | 1.6 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
1.6 | 8.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.6 | 4.9 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.6 | 13.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
1.6 | 3.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.6 | 1.6 | GO:0002576 | platelet degranulation(GO:0002576) |
1.6 | 17.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
1.6 | 8.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.6 | 4.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.6 | 1.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
1.6 | 12.9 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
1.6 | 3.2 | GO:0071467 | cellular response to pH(GO:0071467) |
1.6 | 3.2 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
1.6 | 4.8 | GO:0009838 | abscission(GO:0009838) |
1.6 | 6.4 | GO:0001893 | maternal placenta development(GO:0001893) |
1.6 | 1.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.6 | 3.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.6 | 3.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.6 | 4.8 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
1.6 | 23.9 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
1.6 | 9.5 | GO:0046415 | urate metabolic process(GO:0046415) |
1.6 | 11.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
1.6 | 4.8 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
1.6 | 6.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.6 | 17.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.6 | 3.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.6 | 1.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
1.6 | 12.5 | GO:0048535 | lymph node development(GO:0048535) |
1.6 | 9.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.6 | 7.8 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
1.6 | 6.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.6 | 7.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.6 | 4.7 | GO:0018158 | protein oxidation(GO:0018158) |
1.6 | 3.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
1.6 | 28.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
1.6 | 15.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
1.6 | 1.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.6 | 3.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.6 | 4.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.6 | 4.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.6 | 37.3 | GO:0070527 | platelet aggregation(GO:0070527) |
1.6 | 1.6 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
1.5 | 4.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.5 | 6.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.5 | 3.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.5 | 4.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.5 | 12.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
1.5 | 3.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.5 | 4.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.5 | 4.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.5 | 4.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
1.5 | 21.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
1.5 | 3.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.5 | 4.6 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.5 | 16.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.5 | 1.5 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
1.5 | 3.0 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
1.5 | 7.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.5 | 1.5 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) regulation of cell proliferation involved in kidney development(GO:1901722) positive regulation of cell proliferation involved in kidney development(GO:1901724) |
1.5 | 4.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.5 | 10.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
1.5 | 3.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
1.5 | 3.0 | GO:0051451 | myoblast migration(GO:0051451) |
1.5 | 4.5 | GO:0015889 | cobalamin transport(GO:0015889) |
1.5 | 4.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.5 | 12.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
1.5 | 3.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
1.5 | 7.5 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
1.5 | 7.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.5 | 1.5 | GO:0009750 | response to fructose(GO:0009750) |
1.5 | 1.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.5 | 7.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.5 | 3.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.5 | 25.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.5 | 7.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.5 | 4.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.5 | 3.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
1.5 | 32.6 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
1.5 | 5.9 | GO:0043297 | apical junction assembly(GO:0043297) |
1.5 | 5.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.5 | 17.7 | GO:0030168 | platelet activation(GO:0030168) |
1.5 | 1.5 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.5 | 4.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.5 | 13.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.5 | 2.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
1.5 | 16.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
1.5 | 7.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.5 | 1.5 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
1.5 | 2.9 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
1.5 | 7.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.5 | 7.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.5 | 4.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.4 | 1.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.4 | 4.3 | GO:0015888 | thiamine transport(GO:0015888) |
1.4 | 2.9 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.4 | 5.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.4 | 1.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.4 | 27.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.4 | 4.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.4 | 13.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.4 | 24.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.4 | 23.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
1.4 | 13.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
1.4 | 5.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
1.4 | 2.9 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
1.4 | 18.7 | GO:0006953 | acute-phase response(GO:0006953) |
1.4 | 5.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
1.4 | 11.5 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
1.4 | 2.9 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
1.4 | 1.4 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.4 | 5.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.4 | 10.0 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
1.4 | 7.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.4 | 8.5 | GO:0051026 | chiasma assembly(GO:0051026) |
1.4 | 4.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
1.4 | 12.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.4 | 1.4 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.4 | 4.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
1.4 | 11.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
1.4 | 7.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.4 | 4.2 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
1.4 | 1.4 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
1.4 | 14.1 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
1.4 | 4.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
1.4 | 1.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
1.4 | 7.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.4 | 4.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
1.4 | 2.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.4 | 5.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
1.4 | 1.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.4 | 4.2 | GO:0033762 | response to glucagon(GO:0033762) |
1.4 | 7.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
1.4 | 2.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.4 | 2.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.4 | 9.8 | GO:0046688 | response to copper ion(GO:0046688) |
1.4 | 1.4 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
1.4 | 1.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.4 | 5.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.4 | 2.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
1.4 | 1.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.4 | 26.3 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
1.4 | 5.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.4 | 2.8 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
1.4 | 5.5 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.4 | 6.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
1.4 | 2.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.4 | 37.3 | GO:0045445 | myoblast differentiation(GO:0045445) |
1.4 | 6.9 | GO:0030575 | nuclear body organization(GO:0030575) |
1.4 | 1.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
1.4 | 1.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.4 | 2.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.4 | 6.8 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
1.4 | 16.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
1.4 | 1.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
1.4 | 4.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.4 | 2.7 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.4 | 4.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.4 | 5.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.4 | 1.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.4 | 6.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
1.4 | 1.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.4 | 5.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.4 | 8.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.4 | 10.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.4 | 2.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.4 | 14.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
1.3 | 6.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.3 | 1.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.3 | 2.7 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
1.3 | 2.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
1.3 | 1.3 | GO:0019081 | viral translation(GO:0019081) |
1.3 | 25.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
1.3 | 10.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
1.3 | 1.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
1.3 | 1.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.3 | 4.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.3 | 2.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
1.3 | 2.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.3 | 23.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.3 | 17.2 | GO:0031648 | protein destabilization(GO:0031648) |
1.3 | 2.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.3 | 5.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.3 | 5.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.3 | 2.6 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.3 | 1.3 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.3 | 3.9 | GO:0045006 | DNA deamination(GO:0045006) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
1.3 | 13.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
1.3 | 3.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.3 | 5.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.3 | 2.6 | GO:0070254 | mucus secretion(GO:0070254) |
1.3 | 1.3 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
1.3 | 5.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.3 | 11.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.3 | 11.6 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.3 | 15.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.3 | 15.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
1.3 | 6.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.3 | 3.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.3 | 1.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.3 | 5.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.3 | 1.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
1.3 | 5.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.3 | 7.6 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
1.3 | 16.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
1.3 | 29.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.3 | 11.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
1.3 | 3.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
1.3 | 1.3 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
1.3 | 3.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.3 | 6.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
1.3 | 6.3 | GO:0060631 | regulation of meiosis I(GO:0060631) |
1.3 | 1.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
1.3 | 3.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.3 | 2.5 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.3 | 12.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.3 | 3.8 | GO:0070269 | pyroptosis(GO:0070269) |
1.3 | 3.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.3 | 1.3 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
1.3 | 13.8 | GO:0051601 | exocyst localization(GO:0051601) |
1.3 | 5.0 | GO:0007144 | female meiosis I(GO:0007144) |
1.3 | 1.3 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
1.2 | 2.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.2 | 2.5 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
1.2 | 34.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
1.2 | 33.5 | GO:0034329 | cell junction assembly(GO:0034329) |
1.2 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.2 | 1.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
1.2 | 3.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.2 | 1.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.2 | 2.5 | GO:0009299 | mRNA transcription(GO:0009299) |
1.2 | 1.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.2 | 3.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.2 | 3.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.2 | 6.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.2 | 1.2 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
1.2 | 18.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
1.2 | 7.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
1.2 | 1.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.2 | 3.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.2 | 3.7 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
1.2 | 2.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.2 | 6.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.2 | 14.5 | GO:0032608 | interferon-beta production(GO:0032608) |
1.2 | 2.4 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
1.2 | 6.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.2 | 1.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
1.2 | 3.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.2 | 1.2 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.2 | 8.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.2 | 2.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.2 | 1.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.2 | 3.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.2 | 4.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.2 | 1.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
1.2 | 8.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.2 | 14.2 | GO:0043489 | RNA stabilization(GO:0043489) |
1.2 | 3.5 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.2 | 1.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.2 | 2.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.2 | 9.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
1.2 | 43.4 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
1.2 | 3.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.2 | 9.3 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
1.2 | 9.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.2 | 10.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
1.2 | 2.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.2 | 3.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
1.2 | 4.6 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.2 | 5.8 | GO:0034063 | stress granule assembly(GO:0034063) |
1.2 | 8.1 | GO:0046051 | UTP metabolic process(GO:0046051) |
1.1 | 1.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.1 | 2.3 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
1.1 | 3.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.1 | 6.9 | GO:0002347 | response to tumor cell(GO:0002347) |
1.1 | 4.6 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
1.1 | 5.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.1 | 3.4 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
1.1 | 1.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
1.1 | 1.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.1 | 4.5 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
1.1 | 5.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.1 | 1.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
1.1 | 11.2 | GO:0001562 | response to protozoan(GO:0001562) |
1.1 | 2.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.1 | 1.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
1.1 | 4.5 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
1.1 | 7.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.1 | 6.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.1 | 1.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
1.1 | 1.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
1.1 | 15.5 | GO:0032612 | interleukin-1 production(GO:0032612) |
1.1 | 4.4 | GO:0007000 | nucleolus organization(GO:0007000) |
1.1 | 14.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
1.1 | 6.6 | GO:0002021 | response to dietary excess(GO:0002021) |
1.1 | 8.8 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.1 | 13.1 | GO:0008272 | sulfate transport(GO:0008272) |
1.1 | 1.1 | GO:0010159 | specification of organ position(GO:0010159) |
1.1 | 6.5 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.1 | 4.4 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.1 | 5.4 | GO:0015858 | nucleoside transport(GO:0015858) |
1.1 | 1.1 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
1.1 | 4.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
1.1 | 5.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.1 | 8.7 | GO:0014850 | response to muscle activity(GO:0014850) |
1.1 | 8.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.1 | 2.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.1 | 4.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
1.1 | 3.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.1 | 2.1 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
1.1 | 4.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.1 | 2.1 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
1.1 | 2.1 | GO:0006534 | cysteine metabolic process(GO:0006534) cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.1 | 1.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
1.1 | 13.7 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
1.1 | 1.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
1.1 | 1.1 | GO:0072665 | protein localization to vacuole(GO:0072665) |
1.1 | 1.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
1.1 | 21.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
1.1 | 1.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.0 | 11.5 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
1.0 | 2.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
1.0 | 5.2 | GO:0071548 | response to dexamethasone(GO:0071548) |
1.0 | 1.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.0 | 2.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.0 | 14.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.0 | 1.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
1.0 | 1.0 | GO:0030042 | actin filament depolymerization(GO:0030042) |
1.0 | 2.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.0 | 3.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
1.0 | 3.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.0 | 3.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
1.0 | 1.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
1.0 | 26.8 | GO:0007569 | cell aging(GO:0007569) |
1.0 | 1.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.0 | 5.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.0 | 3.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.0 | 4.1 | GO:0030238 | male sex determination(GO:0030238) |
1.0 | 1.0 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
1.0 | 1.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.0 | 6.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
1.0 | 6.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.0 | 2.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.0 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.0 | 9.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.0 | 2.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.0 | 1.0 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
1.0 | 2.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.0 | 3.0 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
1.0 | 5.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.0 | 5.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
1.0 | 2.0 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
1.0 | 6.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.0 | 1.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.0 | 3.0 | GO:0051775 | response to redox state(GO:0051775) |
1.0 | 8.0 | GO:0043248 | proteasome assembly(GO:0043248) |
1.0 | 2.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.0 | 20.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.0 | 3.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.0 | 4.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.0 | 1.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
1.0 | 2.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
1.0 | 4.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.0 | 4.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
1.0 | 1.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.0 | 3.0 | GO:1903429 | regulation of cell maturation(GO:1903429) |
1.0 | 7.9 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
1.0 | 2.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.0 | 7.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
1.0 | 1.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.0 | 1.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.0 | 4.9 | GO:0032060 | bleb assembly(GO:0032060) |
1.0 | 1.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.0 | 2.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.0 | 6.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.0 | 1.9 | GO:0072718 | response to cisplatin(GO:0072718) |
1.0 | 1.9 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
1.0 | 5.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
1.0 | 3.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.0 | 1.9 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
1.0 | 12.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
1.0 | 5.8 | GO:0032400 | melanosome localization(GO:0032400) |
1.0 | 1.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
1.0 | 1.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
1.0 | 6.7 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
1.0 | 1.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
1.0 | 2.9 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
1.0 | 3.8 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.9 | 0.9 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.9 | 10.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.9 | 1.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.9 | 14.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.9 | 0.9 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.9 | 2.8 | GO:0036233 | glycine import(GO:0036233) |
0.9 | 3.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.9 | 2.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.9 | 5.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.9 | 7.5 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.9 | 11.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.9 | 0.9 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.9 | 2.8 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.9 | 5.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.9 | 16.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.9 | 4.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.9 | 3.7 | GO:0002931 | response to ischemia(GO:0002931) |
0.9 | 5.5 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.9 | 0.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.9 | 3.6 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.9 | 4.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.9 | 15.5 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.9 | 0.9 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.9 | 0.9 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.9 | 7.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.9 | 0.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.9 | 0.9 | GO:0002833 | positive regulation of response to biotic stimulus(GO:0002833) |
0.9 | 14.4 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.9 | 1.8 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.9 | 1.8 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.9 | 2.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.9 | 0.9 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.9 | 8.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.9 | 9.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.9 | 1.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.9 | 3.6 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.9 | 0.9 | GO:0015747 | urate transport(GO:0015747) |
0.9 | 4.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.9 | 5.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.9 | 0.9 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.9 | 12.4 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.9 | 2.6 | GO:0070305 | response to cGMP(GO:0070305) |
0.9 | 4.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.9 | 1.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.9 | 0.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.9 | 8.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.9 | 2.6 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.9 | 1.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.9 | 0.9 | GO:0001555 | oocyte growth(GO:0001555) |
0.9 | 7.7 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.9 | 0.9 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.9 | 0.9 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.9 | 0.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.9 | 1.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.9 | 11.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.8 | 0.8 | GO:0031639 | plasminogen activation(GO:0031639) |
0.8 | 4.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.8 | 16.0 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.8 | 5.9 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.8 | 0.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.8 | 5.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.8 | 4.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.8 | 29.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.8 | 9.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.8 | 3.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.8 | 9.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.8 | 0.8 | GO:0019042 | viral latency(GO:0019042) |
0.8 | 3.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.8 | 0.8 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.8 | 2.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.8 | 4.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.8 | 3.2 | GO:0015809 | arginine transport(GO:0015809) |
0.8 | 5.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.8 | 1.6 | GO:0051785 | positive regulation of nuclear division(GO:0051785) |
0.8 | 2.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.8 | 1.6 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.8 | 0.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.8 | 3.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.8 | 4.0 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.8 | 3.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.8 | 3.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.8 | 3.1 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.8 | 0.8 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.8 | 0.8 | GO:0015669 | gas transport(GO:0015669) |
0.8 | 1.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.8 | 0.8 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.8 | 3.9 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.8 | 3.9 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.8 | 1.6 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.8 | 0.8 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.8 | 3.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.8 | 10.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.8 | 1.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.8 | 11.5 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.8 | 0.8 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.8 | 4.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.8 | 3.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.8 | 0.8 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.8 | 1.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.8 | 1.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.8 | 1.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.8 | 3.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.7 | 0.7 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.7 | 6.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.7 | 1.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.7 | 2.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.7 | 2.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.7 | 0.7 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.7 | 2.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.7 | 5.2 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.7 | 4.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.7 | 1.5 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.7 | 3.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.7 | 0.7 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.7 | 1.5 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.7 | 0.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.7 | 1.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.7 | 1.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 1.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 6.5 | GO:0035904 | aorta development(GO:0035904) |
0.7 | 3.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.7 | 13.6 | GO:0031497 | chromatin assembly(GO:0031497) |
0.7 | 1.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.7 | 2.9 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.7 | 7.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.7 | 0.7 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.7 | 1.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.7 | 4.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.7 | 1.4 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.7 | 0.7 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.7 | 4.2 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
0.7 | 2.8 | GO:0030104 | water homeostasis(GO:0030104) |
0.7 | 7.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.7 | 4.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.7 | 0.7 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.7 | 0.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.7 | 2.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.7 | 0.7 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.7 | 2.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.7 | 10.4 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.7 | 2.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.7 | 0.7 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.7 | 2.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.7 | 9.6 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.7 | 0.7 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.7 | 0.7 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.7 | 2.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.7 | 0.7 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.7 | 5.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.7 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 3.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.7 | 6.8 | GO:0006828 | manganese ion transport(GO:0006828) |
0.7 | 45.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.7 | 1.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.7 | 0.7 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.7 | 0.7 | GO:0048069 | eye pigmentation(GO:0048069) |
0.7 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 1.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.7 | 0.7 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.7 | 0.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.7 | 0.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.7 | 2.0 | GO:0042026 | protein refolding(GO:0042026) |
0.7 | 0.7 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.7 | 14.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.7 | 13.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.7 | 1.3 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.7 | 5.2 | GO:0051923 | sulfation(GO:0051923) |
0.7 | 2.0 | GO:0014823 | response to activity(GO:0014823) |
0.7 | 9.1 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.6 | 3.9 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.6 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.6 | 9.7 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.6 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.6 | 1.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.6 | 3.9 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.6 | 1.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.6 | 10.3 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.6 | 1.9 | GO:0045176 | apical protein localization(GO:0045176) |
0.6 | 0.6 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.6 | 0.6 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.6 | 5.1 | GO:0060065 | uterus development(GO:0060065) |
0.6 | 3.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.6 | 3.2 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.6 | 0.6 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.6 | 1.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 0.6 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.6 | 2.5 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.6 | 1.9 | GO:0080111 | DNA demethylation(GO:0080111) |
0.6 | 1.3 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.6 | 6.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.6 | 1.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.6 | 0.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.6 | 8.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.6 | 3.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.6 | 11.1 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.6 | 0.6 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.6 | 3.7 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.6 | 7.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.6 | 0.6 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.6 | 0.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.6 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 1.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.6 | 6.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.6 | 1.8 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 1.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.6 | 1.2 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.6 | 3.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.6 | 0.6 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.6 | 9.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.6 | 2.4 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.6 | 1.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.6 | 1.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 1.8 | GO:0034204 | lipid translocation(GO:0034204) |
0.6 | 0.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.6 | 10.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.6 | 0.6 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.6 | 0.6 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.6 | 5.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.6 | 3.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.6 | 7.6 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.6 | 0.6 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.6 | 2.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 0.6 | GO:0060157 | urinary bladder development(GO:0060157) |
0.6 | 5.8 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.6 | 0.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.6 | 0.6 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.6 | 1.7 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.6 | 0.6 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.6 | 4.5 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.6 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 2.3 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
0.6 | 3.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.6 | 1.7 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 1.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.6 | 2.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.6 | 1.7 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.6 | 0.6 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.6 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.6 | 7.7 | GO:0060324 | face development(GO:0060324) |
0.6 | 1.7 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.5 | 4.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.5 | 6.0 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.5 | 1.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 7.1 | GO:0048538 | thymus development(GO:0048538) |
0.5 | 0.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.5 | 0.5 | GO:0034505 | tooth mineralization(GO:0034505) |
0.5 | 1.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.5 | 2.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.5 | 39.1 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
0.5 | 2.7 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.5 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.5 | 5.3 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.5 | 1.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 4.7 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.5 | 2.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.5 | 11.5 | GO:1901998 | toxin transport(GO:1901998) |
0.5 | 3.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.5 | 1.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.5 | 1.6 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.5 | 0.5 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.5 | 0.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.5 | 17.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.5 | 1.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.5 | 1.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 1.5 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.5 | 0.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 1.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.5 | 2.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.5 | 1.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.5 | 0.5 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.5 | 0.5 | GO:0046386 | deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
0.5 | 1.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 5.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 2.9 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.5 | 2.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.5 | 0.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.5 | 6.3 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.5 | 1.5 | GO:0015893 | drug transport(GO:0015893) |
0.5 | 1.0 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.5 | 4.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.5 | 5.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.5 | 0.5 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.5 | 0.5 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.5 | 0.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 1.9 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.5 | 6.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.5 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.5 | 6.1 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.5 | 0.9 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.5 | 0.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.5 | 1.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.5 | 1.4 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.5 | 0.5 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.5 | 0.5 | GO:0030421 | defecation(GO:0030421) |
0.5 | 20.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.5 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 0.5 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.5 | 1.8 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.5 | 6.4 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.5 | 1.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.5 | 1.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.5 | 0.5 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.4 | 2.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 0.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.4 | 0.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 10.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 1.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 4.0 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.4 | 6.6 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.4 | 12.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.4 | 0.4 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.4 | 1.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 2.6 | GO:0007379 | segment specification(GO:0007379) |
0.4 | 54.2 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.4 | 8.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.4 | 0.8 | GO:0097205 | renal filtration(GO:0097205) |
0.4 | 0.8 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.4 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 1.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.4 | 9.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 1.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.4 | 0.4 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.4 | 0.4 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.4 | 1.2 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.4 | 0.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.4 | 1.2 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.4 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 1.6 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.4 | 0.4 | GO:0050926 | Tie signaling pathway(GO:0048014) regulation of positive chemotaxis(GO:0050926) |
0.4 | 0.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 0.4 | GO:2000848 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of glucocorticoid secretion(GO:2000851) |
0.4 | 3.6 | GO:0030239 | myofibril assembly(GO:0030239) |
0.4 | 0.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 1.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 0.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.4 | 2.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.4 | 1.5 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 0.4 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 1.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 0.8 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.4 | 1.5 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 0.4 | GO:0000237 | leptotene(GO:0000237) |
0.4 | 2.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 0.4 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.4 | 2.9 | GO:0031167 | rRNA methylation(GO:0031167) |
0.4 | 4.0 | GO:0042181 | ketone biosynthetic process(GO:0042181) |
0.4 | 0.7 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.4 | 1.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.4 | 2.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 2.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.4 | 1.4 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.4 | 1.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.4 | 1.1 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.3 | 0.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 0.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 0.7 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 2.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 1.0 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.3 | 3.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.3 | 2.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 0.3 | GO:0098754 | detoxification(GO:0098754) |
0.3 | 3.2 | GO:0001947 | heart looping(GO:0001947) |
0.3 | 3.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.3 | 25.2 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.3 | 7.7 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 4.1 | GO:0097191 | extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 0.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.3 | 0.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.3 | 0.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 5.6 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.3 | 9.3 | GO:0050817 | blood coagulation(GO:0007596) coagulation(GO:0050817) |
0.3 | 3.4 | GO:0015758 | glucose transport(GO:0015758) |
0.3 | 0.3 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.3 | 0.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 1.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.3 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 0.9 | GO:0097459 | copper ion import(GO:0015677) ferric iron import(GO:0033216) iron ion import into cell(GO:0097459) ferric iron import into cell(GO:0097461) |
0.3 | 1.8 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 1.5 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.3 | 1.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.3 | 6.3 | GO:0002237 | response to molecule of bacterial origin(GO:0002237) |
0.3 | 0.3 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.3 | 4.7 | GO:0003341 | cilium movement(GO:0003341) |
0.3 | 3.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.5 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.3 | 0.3 | GO:0051132 | NK T cell activation(GO:0051132) |
0.3 | 0.9 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.3 | 0.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 7.5 | GO:0042060 | wound healing(GO:0042060) |
0.3 | 0.6 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.9 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 3.7 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.3 | 4.6 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.3 | 12.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.3 | 0.6 | GO:0043144 | snoRNA processing(GO:0043144) |
0.3 | 0.3 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.3 | 0.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 0.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.3 | 2.2 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 0.5 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.3 | 0.5 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.3 | 0.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.3 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 0.3 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.3 | 2.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.3 | 0.3 | GO:0071827 | plasma lipoprotein particle organization(GO:0071827) |
0.3 | 1.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 0.3 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.3 | 2.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.3 | 0.5 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.3 | 4.4 | GO:0009988 | cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.2 | 0.7 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.2 | 0.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 1.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 1.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 1.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 1.7 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.2 | 0.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.5 | GO:0046209 | nitric oxide metabolic process(GO:0046209) |
0.2 | 3.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 0.5 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.2 | 3.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 1.2 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.2 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.2 | 3.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 19.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 0.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 2.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 6.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 2.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 2.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 3.2 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.2 | 0.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 0.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.6 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.2 | 1.0 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.2 | 0.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 1.8 | GO:0006476 | protein deacetylation(GO:0006476) |
0.2 | 0.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 0.6 | GO:0048599 | oocyte development(GO:0048599) |
0.2 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.4 | GO:0031331 | positive regulation of cellular catabolic process(GO:0031331) |
0.2 | 1.9 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.2 | 0.2 | GO:0070542 | response to fatty acid(GO:0070542) |
0.2 | 0.7 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.2 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.2 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.3 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 1.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 1.5 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.2 | 0.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.8 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.1 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
0.1 | 0.1 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.1 | 0.1 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.7 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.4 | GO:1902268 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 6.7 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 24.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 2.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.6 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.4 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.3 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.1 | 1.9 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.6 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 2.8 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 1.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.4 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 1.6 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 4.3 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 5.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 3.2 | GO:0070482 | response to oxygen levels(GO:0070482) |
0.1 | 0.2 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.1 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.3 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 6.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.5 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.5 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 1.1 | GO:0001824 | blastocyst development(GO:0001824) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 1.8 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.0 | 0.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.0 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.3 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 3.7 | GO:0006412 | translation(GO:0006412) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.4 | 28.1 | GO:0097443 | sorting endosome(GO:0097443) |
9.0 | 17.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
8.1 | 24.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
7.7 | 23.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
7.7 | 15.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
7.6 | 30.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
7.5 | 30.0 | GO:0030689 | Noc complex(GO:0030689) |
7.3 | 36.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
6.9 | 20.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
6.8 | 27.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
6.8 | 34.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
6.7 | 20.1 | GO:0097413 | Lewy body(GO:0097413) |
6.7 | 20.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
6.6 | 19.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
6.4 | 12.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
6.4 | 25.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
6.1 | 61.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
6.0 | 30.2 | GO:0005638 | lamin filament(GO:0005638) |
6.0 | 18.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
5.9 | 29.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
5.3 | 16.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
5.2 | 15.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
5.2 | 31.3 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
5.1 | 15.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
5.0 | 39.9 | GO:0005861 | troponin complex(GO:0005861) |
4.9 | 4.9 | GO:0030175 | filopodium(GO:0030175) actin-based cell projection(GO:0098858) |
4.9 | 24.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
4.8 | 14.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
4.8 | 33.6 | GO:0030056 | hemidesmosome(GO:0030056) |
4.8 | 38.4 | GO:0016600 | flotillin complex(GO:0016600) |
4.7 | 32.8 | GO:0042382 | paraspeckles(GO:0042382) |
4.7 | 18.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
4.6 | 27.5 | GO:1990462 | omegasome(GO:1990462) |
4.5 | 17.9 | GO:0072487 | MSL complex(GO:0072487) |
4.5 | 26.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
4.4 | 13.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
4.4 | 65.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
4.3 | 8.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
4.3 | 21.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
4.3 | 17.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
4.2 | 46.6 | GO:0002102 | podosome(GO:0002102) |
4.2 | 4.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
4.2 | 16.7 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
4.1 | 16.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
4.1 | 20.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
4.1 | 239.2 | GO:0032432 | actin filament bundle(GO:0032432) |
4.0 | 8.1 | GO:0031523 | Myb complex(GO:0031523) |
4.0 | 4.0 | GO:0071565 | nBAF complex(GO:0071565) |
4.0 | 15.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
3.9 | 11.6 | GO:0043293 | apoptosome(GO:0043293) |
3.8 | 22.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
3.7 | 11.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.7 | 51.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
3.7 | 25.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
3.6 | 10.8 | GO:1990635 | proximal dendrite(GO:1990635) |
3.6 | 21.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
3.6 | 7.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
3.5 | 35.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
3.5 | 10.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
3.4 | 6.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
3.4 | 20.4 | GO:0032009 | early phagosome(GO:0032009) |
3.4 | 37.1 | GO:0043034 | costamere(GO:0043034) |
3.4 | 70.8 | GO:0008305 | integrin complex(GO:0008305) |
3.3 | 26.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
3.3 | 16.5 | GO:0005818 | aster(GO:0005818) |
3.3 | 29.6 | GO:0042641 | actomyosin(GO:0042641) |
3.3 | 9.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
3.3 | 3.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
3.3 | 35.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
3.2 | 3.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
3.2 | 22.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
3.2 | 6.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
3.2 | 9.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
3.2 | 22.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
3.2 | 12.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
3.1 | 9.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
3.1 | 28.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
3.1 | 9.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
3.1 | 21.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
3.1 | 9.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
3.1 | 24.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
3.1 | 6.1 | GO:0016939 | kinesin II complex(GO:0016939) |
3.0 | 15.0 | GO:0008091 | spectrin(GO:0008091) |
3.0 | 14.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.9 | 14.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
2.9 | 17.7 | GO:0031209 | SCAR complex(GO:0031209) |
2.9 | 17.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.9 | 32.1 | GO:0031528 | microvillus membrane(GO:0031528) |
2.8 | 8.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
2.8 | 8.5 | GO:0000322 | storage vacuole(GO:0000322) |
2.8 | 33.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
2.8 | 5.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.8 | 5.6 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.8 | 14.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.8 | 11.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
2.8 | 22.1 | GO:0097470 | ribbon synapse(GO:0097470) |
2.8 | 11.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
2.7 | 11.0 | GO:0005642 | annulate lamellae(GO:0005642) |
2.7 | 13.7 | GO:0031143 | pseudopodium(GO:0031143) |
2.7 | 10.9 | GO:0071203 | WASH complex(GO:0071203) |
2.6 | 148.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.6 | 10.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.6 | 7.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
2.6 | 114.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
2.6 | 7.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.6 | 23.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
2.6 | 148.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
2.6 | 7.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.5 | 10.2 | GO:0071953 | elastic fiber(GO:0071953) |
2.5 | 7.6 | GO:0044194 | cytolytic granule(GO:0044194) |
2.5 | 20.1 | GO:0001650 | fibrillar center(GO:0001650) |
2.5 | 5.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.5 | 2.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
2.5 | 5.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
2.5 | 9.9 | GO:0000938 | GARP complex(GO:0000938) |
2.5 | 7.4 | GO:1990423 | RZZ complex(GO:1990423) |
2.5 | 12.3 | GO:0070938 | contractile ring(GO:0070938) |
2.5 | 27.0 | GO:0001891 | phagocytic cup(GO:0001891) |
2.4 | 19.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
2.4 | 28.8 | GO:0031430 | M band(GO:0031430) |
2.4 | 2.4 | GO:0001652 | granular component(GO:0001652) |
2.4 | 18.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
2.4 | 11.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
2.4 | 70.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
2.3 | 7.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.3 | 4.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
2.3 | 14.0 | GO:0005916 | fascia adherens(GO:0005916) |
2.3 | 2.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
2.3 | 7.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
2.3 | 2.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.3 | 50.2 | GO:0001772 | immunological synapse(GO:0001772) |
2.3 | 11.4 | GO:0043219 | lateral loop(GO:0043219) |
2.3 | 15.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
2.3 | 20.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
2.3 | 9.1 | GO:0030914 | STAGA complex(GO:0030914) |
2.3 | 74.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.3 | 24.8 | GO:0010008 | endosome membrane(GO:0010008) |
2.3 | 6.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.2 | 4.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.2 | 4.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.2 | 17.8 | GO:0042627 | chylomicron(GO:0042627) |
2.2 | 2.2 | GO:0000125 | PCAF complex(GO:0000125) |
2.2 | 11.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.2 | 30.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
2.2 | 4.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.2 | 8.7 | GO:0005915 | zonula adherens(GO:0005915) |
2.2 | 13.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
2.2 | 6.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.1 | 6.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
2.1 | 23.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
2.1 | 2.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
2.1 | 12.7 | GO:0042629 | mast cell granule(GO:0042629) |
2.1 | 8.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
2.1 | 6.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.1 | 88.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.1 | 14.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
2.1 | 14.6 | GO:0045179 | apical cortex(GO:0045179) |
2.1 | 6.2 | GO:0000811 | GINS complex(GO:0000811) |
2.1 | 8.3 | GO:1990130 | Iml1 complex(GO:1990130) |
2.1 | 8.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
2.1 | 51.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
2.1 | 10.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
2.0 | 10.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
2.0 | 8.2 | GO:0097452 | GAIT complex(GO:0097452) |
2.0 | 20.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.0 | 16.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
2.0 | 8.1 | GO:0042583 | chromaffin granule(GO:0042583) |
2.0 | 4.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.0 | 2.0 | GO:0000346 | transcription export complex(GO:0000346) |
2.0 | 4.0 | GO:0033269 | internode region of axon(GO:0033269) |
2.0 | 3.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.9 | 3.9 | GO:0005914 | spot adherens junction(GO:0005914) |
1.9 | 33.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.9 | 34.8 | GO:0045120 | pronucleus(GO:0045120) |
1.9 | 5.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.9 | 1.9 | GO:0031090 | organelle membrane(GO:0031090) |
1.9 | 5.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.9 | 11.3 | GO:0042587 | glycogen granule(GO:0042587) |
1.9 | 1.9 | GO:0061574 | ASAP complex(GO:0061574) |
1.9 | 42.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.9 | 1.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.8 | 1.8 | GO:0033270 | paranode region of axon(GO:0033270) |
1.8 | 429.7 | GO:0030055 | cell-substrate junction(GO:0030055) |
1.8 | 5.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.8 | 5.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
1.8 | 19.5 | GO:0035102 | PRC1 complex(GO:0035102) |
1.8 | 45.7 | GO:0016592 | mediator complex(GO:0016592) |
1.8 | 42.1 | GO:0005776 | autophagosome(GO:0005776) |
1.7 | 12.2 | GO:0031931 | TORC1 complex(GO:0031931) |
1.7 | 12.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.7 | 32.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.7 | 19.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.7 | 1.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.7 | 136.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.7 | 6.8 | GO:0035339 | SPOTS complex(GO:0035339) |
1.7 | 5.1 | GO:0005745 | m-AAA complex(GO:0005745) |
1.7 | 5.1 | GO:0000228 | nuclear chromosome(GO:0000228) |
1.7 | 33.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.6 | 14.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.6 | 4.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.6 | 3.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
1.6 | 14.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.6 | 17.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.6 | 136.6 | GO:0005903 | brush border(GO:0005903) |
1.6 | 9.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.6 | 78.1 | GO:0005811 | lipid particle(GO:0005811) |
1.6 | 19.1 | GO:0043196 | varicosity(GO:0043196) |
1.6 | 9.5 | GO:0044327 | dendritic spine head(GO:0044327) |
1.6 | 4.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.6 | 14.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.6 | 3.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.5 | 37.0 | GO:0097228 | sperm principal piece(GO:0097228) |
1.5 | 16.9 | GO:0031672 | A band(GO:0031672) |
1.5 | 9.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.5 | 32.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.5 | 4.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.5 | 9.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
1.5 | 9.1 | GO:0034709 | methylosome(GO:0034709) |
1.5 | 4.5 | GO:0005712 | chiasma(GO:0005712) |
1.5 | 18.0 | GO:0010369 | chromocenter(GO:0010369) |
1.5 | 9.0 | GO:0090543 | Flemming body(GO:0090543) |
1.5 | 6.0 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.5 | 3.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.5 | 73.2 | GO:0016363 | nuclear matrix(GO:0016363) |
1.5 | 21.9 | GO:0000145 | exocyst(GO:0000145) |
1.4 | 8.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.4 | 2.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
1.4 | 2.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.4 | 7.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.4 | 4.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.4 | 1.4 | GO:0005686 | U2 snRNP(GO:0005686) |
1.4 | 73.3 | GO:0016605 | PML body(GO:0016605) |
1.4 | 8.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.4 | 1.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.4 | 77.2 | GO:0005938 | cell cortex(GO:0005938) |
1.4 | 12.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.4 | 18.1 | GO:0005682 | U5 snRNP(GO:0005682) |
1.4 | 27.6 | GO:0000786 | nucleosome(GO:0000786) |
1.4 | 5.5 | GO:0005796 | Golgi lumen(GO:0005796) |
1.4 | 2.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.4 | 45.1 | GO:0045171 | intercellular bridge(GO:0045171) |
1.4 | 16.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.4 | 4.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.4 | 25.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.3 | 2.7 | GO:0051286 | cell tip(GO:0051286) |
1.3 | 4.0 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
1.3 | 5.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.3 | 6.7 | GO:0005827 | polar microtubule(GO:0005827) |
1.3 | 4.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.3 | 11.9 | GO:0070852 | cell body fiber(GO:0070852) |
1.3 | 18.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.3 | 27.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.3 | 2.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.3 | 9.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
1.3 | 7.8 | GO:0099513 | supramolecular fiber(GO:0099512) polymeric cytoskeletal fiber(GO:0099513) |
1.3 | 7.8 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
1.3 | 15.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.3 | 2.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.3 | 2.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.3 | 16.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
1.3 | 13.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
1.3 | 9.0 | GO:0000242 | pericentriolar material(GO:0000242) |
1.3 | 1.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.3 | 2.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.3 | 22.8 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
1.3 | 3.8 | GO:0000812 | Swr1 complex(GO:0000812) |
1.3 | 2.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.3 | 8.8 | GO:0033263 | CORVET complex(GO:0033263) |
1.3 | 5.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.2 | 18.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.2 | 2.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.2 | 7.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.2 | 4.9 | GO:0097255 | R2TP complex(GO:0097255) |
1.2 | 40.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.2 | 9.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.2 | 28.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.2 | 6.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.2 | 2.4 | GO:0030870 | Mre11 complex(GO:0030870) |
1.2 | 12.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.2 | 16.9 | GO:0097546 | ciliary base(GO:0097546) |
1.2 | 1.2 | GO:0042827 | platelet dense granule(GO:0042827) |
1.2 | 8.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.2 | 4.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.2 | 4.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.2 | 5.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.2 | 28.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.2 | 9.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.1 | 28.7 | GO:0015030 | Cajal body(GO:0015030) |
1.1 | 13.7 | GO:0031519 | PcG protein complex(GO:0031519) |
1.1 | 2.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
1.1 | 8.0 | GO:0045178 | basal part of cell(GO:0045178) |
1.1 | 8.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
1.1 | 8.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.1 | 11.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.1 | 11.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.1 | 3.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.1 | 16.7 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
1.1 | 3.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.1 | 5.5 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
1.1 | 9.9 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
1.1 | 3.3 | GO:0034464 | BBSome(GO:0034464) |
1.1 | 4.4 | GO:0071439 | clathrin complex(GO:0071439) |
1.1 | 8.7 | GO:0070652 | HAUS complex(GO:0070652) |
1.1 | 3.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.1 | 8.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.1 | 9.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.1 | 117.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.1 | 45.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
1.1 | 5.3 | GO:0042599 | lamellar body(GO:0042599) |
1.0 | 2.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.0 | 1.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.0 | 5.2 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
1.0 | 3.1 | GO:0035838 | growing cell tip(GO:0035838) |
1.0 | 205.4 | GO:0005667 | transcription factor complex(GO:0005667) |
1.0 | 8.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.0 | 3.1 | GO:0044299 | C-fiber(GO:0044299) |
1.0 | 12.2 | GO:0005876 | spindle microtubule(GO:0005876) |
1.0 | 4.0 | GO:0072687 | meiotic spindle(GO:0072687) |
1.0 | 4.0 | GO:0031512 | motile primary cilium(GO:0031512) |
1.0 | 8.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.0 | 5.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.0 | 5.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.0 | 3.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.0 | 10.9 | GO:0005657 | replication fork(GO:0005657) |
1.0 | 6.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.0 | 27.7 | GO:0005902 | microvillus(GO:0005902) |
1.0 | 11.8 | GO:0005771 | multivesicular body(GO:0005771) |
1.0 | 13.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.0 | 2.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.0 | 1.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.0 | 40.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.9 | 2.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.9 | 3.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.9 | 0.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 0.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.9 | 5.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.9 | 12.0 | GO:0036038 | MKS complex(GO:0036038) |
0.9 | 34.1 | GO:0045095 | keratin filament(GO:0045095) |
0.9 | 0.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 0.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.9 | 4.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.9 | 3.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.9 | 6.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.9 | 9.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.9 | 10.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.9 | 9.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.9 | 19.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.9 | 2.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.9 | 28.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.9 | 3.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.9 | 4.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.9 | 2.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.9 | 1.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.9 | 7.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.9 | 14.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.8 | 7.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.8 | 19.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.8 | 77.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.8 | 2.5 | GO:0098536 | deuterosome(GO:0098536) |
0.8 | 4.2 | GO:0000796 | condensin complex(GO:0000796) |
0.8 | 6.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.8 | 25.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.8 | 14.9 | GO:0005922 | connexon complex(GO:0005922) |
0.8 | 9.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.8 | 5.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.8 | 9.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.8 | 4.1 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 15.6 | GO:0016459 | myosin complex(GO:0016459) |
0.8 | 2.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.8 | 5.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.8 | 3.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.8 | 8.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.8 | 4.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.8 | 23.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.8 | 13.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.8 | 7.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.8 | 868.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.8 | 4.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.8 | 8.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.8 | 52.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.8 | 45.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.8 | 0.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.8 | 9.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.8 | 7.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.8 | 10.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.8 | 25.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.8 | 12.1 | GO:0032420 | stereocilium(GO:0032420) |
0.7 | 29.2 | GO:0005814 | centriole(GO:0005814) |
0.7 | 3.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.7 | 42.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.7 | 6.7 | GO:1902911 | protein kinase complex(GO:1902911) |
0.7 | 3.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.7 | 2.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.7 | 9.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.7 | 3.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.7 | 2.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.7 | 1.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.7 | 24.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.7 | 560.3 | GO:0005829 | cytosol(GO:0005829) |
0.7 | 3.6 | GO:0043218 | compact myelin(GO:0043218) |
0.7 | 10.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.7 | 2.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.7 | 2.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.7 | 13.5 | GO:0030496 | midbody(GO:0030496) |
0.7 | 2.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 0.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.7 | 1.4 | GO:0000835 | cytoplasmic ubiquitin ligase complex(GO:0000153) ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.7 | 2.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 3.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.7 | 1.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.7 | 1.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 85.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.7 | 1.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 9.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 3.2 | GO:0000785 | chromatin(GO:0000785) |
0.6 | 2.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.6 | 1.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 1.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 16.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.6 | 753.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.6 | 6.6 | GO:0005770 | late endosome(GO:0005770) |
0.6 | 22.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.6 | 26.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.6 | 1.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.6 | 25.9 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.5 | 1.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.5 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 12.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.5 | 2.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 12.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.5 | 3.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 1.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.5 | 10.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.5 | 66.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.5 | 3.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.5 | 17.3 | GO:0031514 | motile cilium(GO:0031514) |
0.5 | 43.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.5 | 1.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.5 | 1.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 0.4 | GO:0098588 | bounding membrane of organelle(GO:0098588) |
0.4 | 1.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 6.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 283.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.4 | 4.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.4 | 0.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 0.4 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 3.9 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 4.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 4.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.3 | 3.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 0.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 3.7 | GO:0098687 | chromosomal region(GO:0098687) |
0.3 | 0.5 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.3 | 28.4 | GO:0098552 | side of membrane(GO:0098552) |
0.2 | 1.2 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 9.4 | GO:0012505 | endomembrane system(GO:0012505) |
0.2 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.2 | GO:0044440 | endosomal part(GO:0044440) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 6.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 7.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 4.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.2 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.2 | 16.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 4.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 348.7 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 43.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.2 | 33.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
10.7 | 63.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
10.6 | 31.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
9.7 | 29.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
9.4 | 28.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
8.4 | 101.2 | GO:0017166 | vinculin binding(GO:0017166) |
8.4 | 25.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
8.2 | 57.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
7.8 | 7.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
7.5 | 29.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
7.1 | 42.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
7.0 | 35.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
7.0 | 20.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
6.5 | 19.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
6.5 | 45.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
6.5 | 25.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
6.4 | 57.8 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
6.4 | 19.3 | GO:0035877 | death effector domain binding(GO:0035877) |
6.4 | 25.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
6.4 | 25.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
6.4 | 31.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
6.3 | 43.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
6.1 | 24.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
6.1 | 36.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
6.0 | 6.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
6.0 | 17.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
5.9 | 5.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
5.9 | 17.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
5.8 | 58.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
5.7 | 45.7 | GO:0008430 | selenium binding(GO:0008430) |
5.7 | 17.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
5.7 | 28.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
5.5 | 16.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
5.5 | 16.5 | GO:0030172 | troponin C binding(GO:0030172) |
5.4 | 27.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
5.4 | 16.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
5.3 | 15.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
5.3 | 36.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
5.3 | 5.3 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
5.2 | 15.6 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
5.2 | 20.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
5.1 | 15.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
5.0 | 15.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
5.0 | 14.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
4.8 | 14.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
4.8 | 14.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
4.8 | 24.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
4.7 | 14.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
4.7 | 14.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
4.7 | 28.1 | GO:0016936 | galactoside binding(GO:0016936) |
4.7 | 14.0 | GO:0031014 | troponin T binding(GO:0031014) |
4.7 | 18.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
4.6 | 27.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
4.6 | 54.6 | GO:0044548 | S100 protein binding(GO:0044548) |
4.5 | 13.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
4.5 | 18.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
4.5 | 18.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
4.5 | 40.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
4.4 | 17.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
4.4 | 17.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
4.4 | 26.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
4.4 | 91.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
4.3 | 17.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
4.3 | 43.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
4.3 | 42.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
4.1 | 16.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
4.1 | 33.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
4.1 | 24.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
4.1 | 16.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
4.1 | 24.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
4.0 | 16.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
4.0 | 12.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
4.0 | 8.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
4.0 | 11.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
4.0 | 15.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
3.9 | 15.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
3.9 | 7.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
3.9 | 23.4 | GO:0008199 | ferric iron binding(GO:0008199) |
3.9 | 15.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
3.8 | 15.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
3.8 | 3.8 | GO:0035197 | siRNA binding(GO:0035197) |
3.8 | 3.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
3.8 | 15.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
3.7 | 29.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
3.7 | 11.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.7 | 18.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
3.6 | 7.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
3.6 | 29.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
3.6 | 7.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
3.6 | 46.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
3.6 | 17.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
3.6 | 17.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
3.6 | 10.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
3.6 | 14.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
3.6 | 32.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.5 | 10.6 | GO:0050692 | DBD domain binding(GO:0050692) |
3.5 | 46.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
3.5 | 10.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
3.5 | 7.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
3.5 | 13.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
3.5 | 31.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
3.5 | 13.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
3.5 | 6.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
3.4 | 68.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
3.4 | 10.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
3.4 | 3.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
3.4 | 13.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
3.4 | 37.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
3.4 | 13.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
3.4 | 16.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
3.3 | 36.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
3.3 | 9.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
3.3 | 23.1 | GO:0050700 | CARD domain binding(GO:0050700) |
3.3 | 26.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
3.3 | 13.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
3.2 | 41.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
3.2 | 9.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
3.1 | 15.6 | GO:0046790 | virion binding(GO:0046790) |
3.1 | 12.5 | GO:0043515 | kinetochore binding(GO:0043515) |
3.1 | 6.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
3.1 | 9.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.1 | 12.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
3.1 | 6.2 | GO:0055100 | adiponectin binding(GO:0055100) |
3.1 | 9.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
3.1 | 9.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
3.1 | 3.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
3.0 | 9.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
3.0 | 6.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
3.0 | 15.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
3.0 | 3.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
3.0 | 12.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
3.0 | 12.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
3.0 | 15.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
3.0 | 9.0 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
3.0 | 6.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
3.0 | 3.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
3.0 | 14.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
3.0 | 6.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
3.0 | 3.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
3.0 | 3.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
3.0 | 17.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
3.0 | 91.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
3.0 | 14.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
3.0 | 8.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
3.0 | 29.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.9 | 8.8 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
2.9 | 5.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
2.9 | 5.8 | GO:0015928 | fucosidase activity(GO:0015928) |
2.9 | 40.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
2.9 | 23.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.9 | 2.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.9 | 83.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
2.9 | 8.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.9 | 39.9 | GO:0008143 | poly(A) binding(GO:0008143) |
2.8 | 11.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
2.8 | 8.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
2.8 | 22.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
2.8 | 5.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
2.8 | 73.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
2.8 | 56.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
2.8 | 25.3 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
2.8 | 36.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
2.8 | 16.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
2.8 | 13.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
2.8 | 16.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
2.8 | 11.1 | GO:0009374 | biotin binding(GO:0009374) |
2.8 | 36.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.8 | 2.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
2.8 | 19.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
2.7 | 8.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.7 | 16.3 | GO:0051400 | BH domain binding(GO:0051400) |
2.7 | 8.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.7 | 19.0 | GO:1990405 | protein antigen binding(GO:1990405) |
2.7 | 8.2 | GO:1990188 | euchromatin binding(GO:1990188) |
2.7 | 8.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
2.7 | 8.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
2.7 | 10.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
2.7 | 18.8 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
2.7 | 10.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.7 | 8.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
2.7 | 8.0 | GO:0030984 | kininogen binding(GO:0030984) |
2.7 | 18.6 | GO:0018650 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
2.7 | 10.6 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
2.6 | 10.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
2.6 | 10.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
2.6 | 15.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.6 | 5.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.6 | 2.6 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
2.6 | 7.9 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
2.6 | 20.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
2.6 | 7.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
2.6 | 10.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.6 | 10.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
2.6 | 12.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.6 | 2.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
2.6 | 12.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.6 | 7.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.6 | 17.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
2.6 | 48.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
2.5 | 7.6 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
2.5 | 7.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
2.5 | 10.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
2.5 | 12.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
2.5 | 77.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
2.5 | 7.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
2.5 | 7.5 | GO:0030519 | snoRNP binding(GO:0030519) |
2.5 | 7.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.5 | 2.5 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
2.5 | 74.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
2.5 | 5.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
2.5 | 19.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.5 | 9.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
2.5 | 2.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
2.5 | 9.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.5 | 9.9 | GO:0015232 | heme transporter activity(GO:0015232) |
2.5 | 9.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
2.5 | 19.7 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
2.5 | 2.5 | GO:0004096 | catalase activity(GO:0004096) |
2.5 | 2.5 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.5 | 12.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.4 | 14.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
2.4 | 9.8 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
2.4 | 14.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
2.4 | 39.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
2.4 | 12.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.4 | 2.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
2.4 | 7.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.4 | 2.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
2.4 | 4.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
2.4 | 2.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
2.4 | 7.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
2.4 | 2.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
2.4 | 7.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
2.4 | 9.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
2.4 | 9.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
2.4 | 9.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.4 | 4.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
2.4 | 16.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.3 | 9.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
2.3 | 14.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
2.3 | 16.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
2.3 | 9.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.3 | 7.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
2.3 | 57.8 | GO:0045296 | cadherin binding(GO:0045296) |
2.3 | 9.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
2.3 | 6.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.3 | 9.2 | GO:0038132 | neuregulin binding(GO:0038132) |
2.3 | 18.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.3 | 6.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.3 | 2.3 | GO:0034618 | arginine binding(GO:0034618) |
2.3 | 11.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.3 | 70.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
2.3 | 6.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
2.3 | 31.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.3 | 4.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
2.2 | 4.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
2.2 | 4.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
2.2 | 13.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
2.2 | 11.1 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
2.2 | 13.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.2 | 4.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
2.2 | 2.2 | GO:0019808 | polyamine binding(GO:0019808) |
2.2 | 22.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
2.2 | 19.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
2.2 | 13.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
2.2 | 21.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
2.2 | 4.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
2.2 | 6.5 | GO:0004103 | choline kinase activity(GO:0004103) |
2.1 | 10.7 | GO:0070061 | fructose binding(GO:0070061) |
2.1 | 10.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
2.1 | 27.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.1 | 10.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
2.1 | 6.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
2.1 | 6.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
2.1 | 4.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
2.1 | 14.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.1 | 10.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.1 | 4.2 | GO:0005534 | galactose binding(GO:0005534) |
2.1 | 18.8 | GO:0005123 | death receptor binding(GO:0005123) |
2.1 | 18.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.1 | 27.0 | GO:0005542 | folic acid binding(GO:0005542) |
2.1 | 10.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.1 | 28.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.1 | 22.7 | GO:0001846 | opsonin binding(GO:0001846) |
2.1 | 4.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.1 | 18.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
2.1 | 51.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
2.0 | 2.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.0 | 28.5 | GO:0005521 | lamin binding(GO:0005521) |
2.0 | 6.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
2.0 | 54.7 | GO:0043236 | laminin binding(GO:0043236) |
2.0 | 6.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.0 | 24.2 | GO:0010181 | FMN binding(GO:0010181) |
2.0 | 10.0 | GO:0017040 | ceramidase activity(GO:0017040) |
2.0 | 4.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
2.0 | 11.9 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
2.0 | 15.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
2.0 | 4.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
2.0 | 4.0 | GO:0004527 | exonuclease activity(GO:0004527) |
2.0 | 11.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
2.0 | 98.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
2.0 | 5.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.0 | 17.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.9 | 7.8 | GO:0030274 | LIM domain binding(GO:0030274) |
1.9 | 27.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.9 | 36.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.9 | 11.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.9 | 17.3 | GO:0031996 | thioesterase binding(GO:0031996) |
1.9 | 5.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.9 | 1.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.9 | 3.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.9 | 3.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.9 | 5.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.9 | 22.5 | GO:0032183 | SUMO binding(GO:0032183) |
1.9 | 18.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.9 | 35.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.9 | 7.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.8 | 3.7 | GO:0015925 | galactosidase activity(GO:0015925) |
1.8 | 156.5 | GO:0051015 | actin filament binding(GO:0051015) |
1.8 | 3.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.8 | 7.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.8 | 1.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.8 | 31.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.8 | 1.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.8 | 5.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.8 | 20.0 | GO:0003785 | actin monomer binding(GO:0003785) |
1.8 | 3.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.8 | 5.4 | GO:0004359 | glutaminase activity(GO:0004359) |
1.8 | 122.8 | GO:0005178 | integrin binding(GO:0005178) |
1.8 | 7.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.8 | 5.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.8 | 25.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.8 | 65.8 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
1.8 | 8.9 | GO:0015288 | porin activity(GO:0015288) |
1.8 | 3.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.8 | 1.8 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.8 | 15.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.8 | 44.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.8 | 7.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.8 | 7.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.8 | 3.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.8 | 43.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.8 | 5.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.8 | 10.5 | GO:0031432 | titin binding(GO:0031432) |
1.7 | 6.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.7 | 5.2 | GO:0035276 | ethanol binding(GO:0035276) |
1.7 | 15.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.7 | 24.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.7 | 12.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.7 | 6.9 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.7 | 49.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.7 | 1.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.7 | 12.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.7 | 15.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.7 | 13.7 | GO:0045703 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.7 | 3.4 | GO:0038100 | nodal binding(GO:0038100) |
1.7 | 6.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.7 | 3.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.7 | 5.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.7 | 10.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.7 | 1.7 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.7 | 6.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.7 | 5.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.7 | 21.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.7 | 5.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.7 | 11.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.7 | 5.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.6 | 1.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.6 | 6.5 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.6 | 3.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.6 | 6.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.6 | 8.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.6 | 4.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.6 | 19.3 | GO:0030955 | potassium ion binding(GO:0030955) |
1.6 | 11.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.6 | 14.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.6 | 1.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.6 | 1.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.6 | 6.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.6 | 9.4 | GO:0035173 | histone kinase activity(GO:0035173) |
1.6 | 17.3 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.6 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.6 | 1.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.6 | 4.7 | GO:0000339 | RNA cap binding(GO:0000339) |
1.5 | 6.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.5 | 3.1 | GO:0015250 | water channel activity(GO:0015250) |
1.5 | 4.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.5 | 4.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.5 | 15.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.5 | 6.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.5 | 25.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.5 | 27.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.5 | 24.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.5 | 6.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.5 | 4.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.5 | 13.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.5 | 10.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.5 | 16.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.5 | 2.9 | GO:0043559 | insulin binding(GO:0043559) |
1.5 | 5.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.5 | 4.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.5 | 7.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.4 | 7.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.4 | 21.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.4 | 18.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.4 | 4.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.4 | 5.7 | GO:0070513 | death domain binding(GO:0070513) |
1.4 | 15.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.4 | 14.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.4 | 5.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
1.4 | 5.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.4 | 5.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.4 | 20.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.4 | 8.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.4 | 4.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.4 | 20.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.4 | 262.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
1.4 | 8.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.4 | 6.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.4 | 13.7 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
1.4 | 10.9 | GO:0031491 | nucleosome binding(GO:0031491) |
1.4 | 12.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.4 | 2.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.4 | 4.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.4 | 10.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.4 | 1.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.3 | 35.1 | GO:0015485 | cholesterol binding(GO:0015485) |
1.3 | 8.1 | GO:0050733 | RS domain binding(GO:0050733) |
1.3 | 88.8 | GO:0001047 | core promoter binding(GO:0001047) |
1.3 | 4.0 | GO:0000182 | rDNA binding(GO:0000182) |
1.3 | 1.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.3 | 5.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.3 | 5.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.3 | 1.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.3 | 4.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
1.3 | 19.8 | GO:0033558 | protein deacetylase activity(GO:0033558) |
1.3 | 17.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
1.3 | 2.6 | GO:0045340 | mercury ion binding(GO:0045340) |
1.3 | 6.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.3 | 4.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.3 | 9.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.3 | 2.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.3 | 3.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.3 | 9.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.3 | 19.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.3 | 2.6 | GO:0031013 | troponin I binding(GO:0031013) |
1.3 | 6.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.3 | 10.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.3 | 60.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.3 | 2.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.3 | 1.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.3 | 1.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.3 | 19.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.3 | 2.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.3 | 6.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.3 | 6.3 | GO:0005536 | glucose binding(GO:0005536) |
1.3 | 5.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.3 | 12.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.3 | 12.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.2 | 2.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.2 | 12.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.2 | 9.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.2 | 7.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.2 | 6.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.2 | 12.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
1.2 | 4.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.2 | 14.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.2 | 3.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.2 | 6.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.2 | 1.2 | GO:0070538 | oleic acid binding(GO:0070538) |
1.2 | 21.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.2 | 6.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.2 | 1.2 | GO:0048156 | tau protein binding(GO:0048156) |
1.2 | 2.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
1.2 | 7.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.2 | 3.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.2 | 9.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.2 | 18.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
1.2 | 2.4 | GO:0019862 | IgA binding(GO:0019862) |
1.2 | 3.6 | GO:0043199 | sulfate binding(GO:0043199) |
1.2 | 183.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
1.2 | 13.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
1.2 | 10.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.2 | 3.5 | GO:0042731 | PH domain binding(GO:0042731) |
1.2 | 8.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.2 | 9.4 | GO:0034783 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
1.2 | 4.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.2 | 11.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.2 | 22.2 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
1.2 | 33.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.2 | 3.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.2 | 1.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.2 | 8.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.2 | 4.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.2 | 4.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.2 | 34.6 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.1 | 5.7 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.1 | 16.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
1.1 | 9.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.1 | 7.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.1 | 4.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.1 | 2.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.1 | 53.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.1 | 6.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.1 | 4.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.1 | 53.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
1.1 | 16.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.1 | 5.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
1.1 | 3.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.1 | 4.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.1 | 5.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.1 | 4.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.1 | 9.8 | GO:0043274 | phospholipase binding(GO:0043274) |
1.1 | 2.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.1 | 42.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.1 | 1.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
1.1 | 3.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.1 | 2.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
1.1 | 7.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.1 | 15.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.1 | 6.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.1 | 2.1 | GO:0019961 | interferon binding(GO:0019961) |
1.1 | 3.2 | GO:0034452 | dynactin binding(GO:0034452) |
1.1 | 5.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.1 | 2.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) guanylyltransferase activity(GO:0070568) |
1.1 | 1.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.1 | 2.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.1 | 1.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.1 | 26.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.1 | 2.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.1 | 3.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.1 | 4.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.1 | 3.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.0 | 8.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.0 | 2.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
1.0 | 5.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.0 | 9.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.0 | 1.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.0 | 1.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.0 | 4.1 | GO:0005113 | patched binding(GO:0005113) |
1.0 | 5.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.0 | 6.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.0 | 107.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.0 | 4.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.0 | 1.0 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.0 | 3.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.0 | 8.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.0 | 4.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.0 | 33.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.0 | 27.7 | GO:0005507 | copper ion binding(GO:0005507) |
1.0 | 4.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.0 | 5.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.0 | 5.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.0 | 3.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 2.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
1.0 | 6.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.0 | 16.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
1.0 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
1.0 | 1.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
1.0 | 1.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.0 | 1.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.0 | 2.9 | GO:0019002 | GMP binding(GO:0019002) |
1.0 | 5.8 | GO:0019825 | oxygen binding(GO:0019825) |
1.0 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
1.0 | 7.6 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
1.0 | 1.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
1.0 | 121.0 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
1.0 | 1.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.0 | 65.6 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.0 | 3.8 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.9 | 1.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.9 | 0.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.9 | 0.9 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.9 | 1.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.9 | 9.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.9 | 13.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.9 | 23.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.9 | 5.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.9 | 1.8 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.9 | 22.0 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.9 | 21.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.9 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.9 | 10.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.9 | 2.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.9 | 24.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.9 | 6.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.9 | 9.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.9 | 3.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.9 | 3.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.9 | 14.2 | GO:0042805 | actinin binding(GO:0042805) |
0.9 | 3.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.9 | 20.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.9 | 2.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.9 | 1.8 | GO:0032052 | bile acid binding(GO:0032052) |
0.9 | 11.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.9 | 72.7 | GO:0008766 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.9 | 3.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.9 | 47.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.9 | 3.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.9 | 7.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.9 | 4.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.9 | 84.8 | GO:0051020 | GTPase binding(GO:0051020) |
0.9 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 75.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.8 | 1.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.8 | 2.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.8 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 2.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.8 | 5.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.8 | 2.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.8 | 5.8 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.8 | 0.8 | GO:0005119 | smoothened binding(GO:0005119) |
0.8 | 180.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.8 | 7.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.8 | 5.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.8 | 3.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.8 | 0.8 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.8 | 4.8 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.8 | 5.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.8 | 35.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.8 | 6.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.8 | 9.4 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.8 | 4.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 0.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.8 | 2.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.8 | 1.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.8 | 1.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 12.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.8 | 8.5 | GO:0016918 | retinal binding(GO:0016918) |
0.8 | 9.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.8 | 5.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.8 | 2.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.8 | 44.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.8 | 16.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.8 | 11.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.8 | 4.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.7 | 19.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.7 | 8.1 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.7 | 10.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.7 | 7.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.7 | 8.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 43.6 | GO:0042393 | histone binding(GO:0042393) |
0.7 | 2.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.7 | 2.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.7 | 1.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 4.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 9.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.7 | 2.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.7 | 0.7 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.7 | 9.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.7 | 14.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.7 | 2.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.7 | 2.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.7 | 1.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.7 | 4.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.7 | 91.0 | GO:0008134 | transcription factor binding(GO:0008134) |
0.7 | 5.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.7 | 8.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.7 | 2.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 16.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.7 | 2.0 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 9.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 11.0 | GO:0032813 | tumor necrosis factor receptor binding(GO:0005164) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.6 | 15.8 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.6 | 4.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.6 | 7.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.6 | 11.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.6 | 0.6 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.6 | 0.6 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.6 | 1.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 25.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.6 | 1.8 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.6 | 3.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.6 | 1.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 7.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.6 | 0.6 | GO:0015927 | trehalase activity(GO:0015927) |
0.6 | 12.1 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 1.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 4.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.6 | 119.3 | GO:0005525 | GTP binding(GO:0005525) |
0.6 | 1.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.6 | 4.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 6.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.6 | 4.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 2.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 2.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 1.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.6 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.6 | 4.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 1.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.6 | 13.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.5 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 1.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 5.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.5 | 1.6 | GO:0002046 | opsin binding(GO:0002046) |
0.5 | 3.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 0.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.5 | 3.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 2.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 5.6 | GO:0090484 | drug transporter activity(GO:0090484) |
0.5 | 1.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 31.0 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.5 | 1.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.5 | 5.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 1.5 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.5 | 3.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 1.0 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.5 | 3.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 16.3 | GO:0060090 | binding, bridging(GO:0060090) |
0.5 | 1.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 5.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.5 | 8.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.5 | 0.5 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.5 | 1.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 3.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 2.8 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.5 | 172.5 | GO:0005198 | structural molecule activity(GO:0005198) |
0.4 | 1.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 1.3 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 8.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 1.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 8.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 2.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 0.4 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.4 | 30.6 | GO:0003774 | motor activity(GO:0003774) |
0.4 | 4.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 1.7 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 4.6 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 11.6 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 1.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 3.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.4 | 1.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.4 | 1.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 23.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.4 | 2.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 1.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 9.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.4 | 1.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 4.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.4 | 6.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 1.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 0.7 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 2.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.4 | 0.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.4 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 2.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 1.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 0.7 | GO:0008297 | exodeoxyribonuclease activity(GO:0004529) single-stranded DNA exodeoxyribonuclease activity(GO:0008297) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.3 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 1.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 3.7 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 18.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 6.2 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.3 | 1.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 3.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.3 | 0.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 7.0 | GO:0002020 | protease binding(GO:0002020) |
0.3 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 0.9 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.3 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 2.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 2.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 14.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 1.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 1.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 3.2 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.2 | 6.4 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.2 | 1.4 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.9 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 3.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 2.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.2 | 4.9 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 0.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.6 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.2 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.6 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.2 | GO:0032934 | sterol binding(GO:0032934) |
0.2 | 0.8 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 15.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.5 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.2 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 7.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 2.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 2.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.2 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.8 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 14.2 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.2 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 1.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 66.2 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 3.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 5.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.4 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.4 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 11.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.1 | 6.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 34.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 5.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
5.3 | 37.3 | ST STAT3 PATHWAY | STAT3 Pathway |
5.0 | 69.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
5.0 | 79.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
4.8 | 82.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
4.8 | 9.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
4.6 | 82.2 | PID IGF1 PATHWAY | IGF1 pathway |
4.6 | 68.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
4.5 | 126.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
4.5 | 104.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
4.4 | 30.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
4.3 | 68.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
4.2 | 89.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
4.2 | 4.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
4.0 | 169.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
4.0 | 52.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
4.0 | 44.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
4.0 | 23.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
4.0 | 106.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
3.7 | 77.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
3.6 | 39.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
3.5 | 136.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
3.4 | 40.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
3.4 | 53.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
3.3 | 46.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
3.3 | 10.0 | PID ALK2 PATHWAY | ALK2 signaling events |
3.2 | 128.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
3.1 | 6.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
3.1 | 53.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
3.1 | 73.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
3.0 | 3.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.9 | 5.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
2.9 | 113.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.9 | 51.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
2.9 | 112.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.9 | 186.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
2.8 | 11.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.8 | 99.8 | PID P53 REGULATION PATHWAY | p53 pathway |
2.7 | 8.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.7 | 18.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
2.7 | 16.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
2.6 | 15.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
2.6 | 28.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
2.6 | 43.7 | PID RHOA PATHWAY | RhoA signaling pathway |
2.6 | 18.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
2.6 | 48.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.6 | 66.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.5 | 12.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.4 | 14.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
2.4 | 16.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.3 | 74.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
2.3 | 50.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
2.3 | 46.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
2.3 | 47.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
2.2 | 42.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
2.2 | 2.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.1 | 19.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
2.1 | 37.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
2.0 | 20.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
2.0 | 23.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
2.0 | 27.4 | PID AURORA A PATHWAY | Aurora A signaling |
2.0 | 60.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.9 | 1.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.9 | 5.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
1.9 | 97.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.9 | 22.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.9 | 9.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.8 | 12.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.8 | 16.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.8 | 52.0 | PID P73PATHWAY | p73 transcription factor network |
1.8 | 24.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.8 | 138.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.7 | 24.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.7 | 3.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.7 | 16.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.7 | 47.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.6 | 26.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.6 | 4.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.6 | 30.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.6 | 25.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.6 | 30.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.6 | 28.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.6 | 19.0 | PID ALK1 PATHWAY | ALK1 signaling events |
1.5 | 42.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.5 | 10.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.5 | 16.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.5 | 32.0 | PID PLK1 PATHWAY | PLK1 signaling events |
1.4 | 47.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.4 | 4.1 | PID IFNG PATHWAY | IFN-gamma pathway |
1.4 | 2.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.3 | 13.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.3 | 10.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.3 | 28.8 | PID AURORA B PATHWAY | Aurora B signaling |
1.2 | 10.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.2 | 14.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.2 | 17.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.2 | 27.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.2 | 5.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.1 | 21.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
1.1 | 5.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.1 | 2.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.1 | 39.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.0 | 6.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.0 | 9.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.0 | 4.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.0 | 14.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.9 | 6.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.9 | 15.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.9 | 10.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.9 | 1.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.9 | 11.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.8 | 6.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.8 | 4.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.8 | 11.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.8 | 4.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.8 | 8.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.8 | 12.4 | PID ATR PATHWAY | ATR signaling pathway |
0.8 | 98.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.8 | 142.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.7 | 28.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.7 | 14.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.7 | 1.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.7 | 7.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 20.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.7 | 2.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.6 | 1.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 8.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.6 | 7.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.6 | 3.9 | PID ATM PATHWAY | ATM pathway |
0.5 | 2.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 4.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 1.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 6.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 3.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 4.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 5.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 3.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 4.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 5.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 2.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 1.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 0.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 3.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 2.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 55.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
5.4 | 21.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
5.1 | 25.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
5.1 | 51.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
4.8 | 61.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
4.7 | 37.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
4.5 | 63.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
4.4 | 66.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
4.4 | 44.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
4.4 | 84.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
4.3 | 76.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
4.1 | 103.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
4.1 | 106.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
4.1 | 40.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
4.1 | 97.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
4.0 | 39.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
3.9 | 3.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
3.9 | 62.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
3.9 | 19.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.9 | 38.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
3.8 | 88.0 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
3.8 | 95.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
3.8 | 11.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
3.7 | 59.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
3.7 | 59.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.7 | 33.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
3.7 | 40.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
3.6 | 25.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
3.5 | 99.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
3.5 | 35.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.4 | 20.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
3.4 | 20.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
3.4 | 40.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
3.3 | 66.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
3.3 | 3.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
3.1 | 18.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
3.1 | 3.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.9 | 29.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.9 | 14.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
2.9 | 66.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
2.9 | 5.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
2.9 | 86.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.8 | 31.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.8 | 31.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.8 | 25.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
2.8 | 25.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.8 | 112.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.7 | 216.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
2.7 | 21.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
2.7 | 8.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
2.7 | 24.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
2.6 | 36.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.6 | 13.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
2.6 | 15.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
2.5 | 2.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.5 | 27.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
2.5 | 10.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
2.5 | 17.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
2.5 | 2.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
2.4 | 7.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
2.4 | 2.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
2.4 | 65.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
2.4 | 25.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
2.3 | 32.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.3 | 2.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
2.3 | 99.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
2.3 | 36.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
2.3 | 9.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
2.3 | 4.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
2.2 | 8.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
2.2 | 17.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
2.2 | 15.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.2 | 11.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
2.2 | 15.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
2.1 | 10.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.0 | 18.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.0 | 12.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
2.0 | 21.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
2.0 | 65.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
2.0 | 7.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
2.0 | 11.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.0 | 7.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
2.0 | 3.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.9 | 42.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.9 | 34.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.9 | 9.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.9 | 59.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.9 | 3.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
1.9 | 18.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.9 | 24.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.8 | 46.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.8 | 22.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.8 | 16.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.8 | 54.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.8 | 26.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.8 | 106.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.8 | 12.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.8 | 161.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.7 | 8.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
1.7 | 36.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.7 | 38.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.7 | 7.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.7 | 26.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.7 | 43.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.7 | 17.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
1.7 | 54.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.7 | 32.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.7 | 3.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.6 | 9.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.6 | 4.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.6 | 70.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.6 | 6.4 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
1.6 | 11.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.6 | 1.6 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
1.6 | 6.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.6 | 12.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.5 | 6.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.5 | 16.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.5 | 16.2 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.5 | 22.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.4 | 7.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.4 | 5.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.4 | 8.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.4 | 5.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.4 | 12.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.4 | 8.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.4 | 28.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.4 | 7.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.4 | 12.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.4 | 5.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.4 | 35.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
1.4 | 42.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.4 | 4.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.4 | 15.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.4 | 57.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.4 | 2.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.3 | 16.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
1.3 | 12.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.3 | 26.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.3 | 34.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.3 | 19.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.3 | 6.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.3 | 1.3 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
1.3 | 111.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
1.3 | 3.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.3 | 43.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
1.3 | 19.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.3 | 3.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.2 | 14.7 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
1.2 | 6.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.2 | 1.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.2 | 3.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.2 | 1.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.2 | 10.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.1 | 8.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.1 | 25.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.1 | 8.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.1 | 11.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.1 | 4.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.1 | 14.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
1.1 | 6.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.1 | 41.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.0 | 31.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.0 | 4.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.0 | 2.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
1.0 | 26.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.9 | 6.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.9 | 40.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.9 | 11.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.9 | 18.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.9 | 8.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.9 | 12.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.9 | 5.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.9 | 4.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.9 | 13.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.9 | 30.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.9 | 79.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.9 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.9 | 12.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.9 | 10.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.9 | 13.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.9 | 0.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.9 | 10.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.9 | 14.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.8 | 21.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.8 | 11.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.8 | 5.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.8 | 13.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.8 | 28.4 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.8 | 2.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.8 | 4.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.8 | 8.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.8 | 2.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.8 | 9.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.8 | 9.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.8 | 3.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.7 | 30.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 16.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.7 | 5.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.7 | 14.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.7 | 2.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.7 | 8.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.7 | 22.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.7 | 7.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 11.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 5.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.6 | 11.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.6 | 6.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.6 | 7.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 7.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 1.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.5 | 1.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.5 | 15.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.5 | 6.8 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.5 | 19.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 78.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 3.6 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.5 | 7.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.5 | 4.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 6.0 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.5 | 0.5 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.5 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 4.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 2.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.5 | 3.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 14.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 3.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 1.3 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.4 | 1.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.4 | 7.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 5.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 6.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 6.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 4.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 5.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 1.8 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.2 | 5.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 2.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 1.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 2.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 0.8 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 9.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 6.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 5.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |